[
  {
    "sentence": "In their absence, the field has only recently begun to build an OCT-based conceptual framework for parameterizing longitudinal “myopic” ONH remodeling.13–16\nIn recent publications,11,12 we have introduced OCT-defined, ONH neural canal and peri-neural canal (pNC) tissue terminology (Figure 1) to identify and distinguish OCT ONH terminology, (which we argue should be based on OCT-detected anatomic landmarks) from the clinical terms “optic disc” and “peripapillary” because these terms, being based on clinical photographic and clinical biomicroscopic assignment of the clinical disc margin, have no consistent OCT-detectable anatomic foundation in the human eye.17,18 Having no consistent anatomic foundation, the clinical disc margin is inconsistently assigned by clinicians18–20 (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Because the clinical disc margin is commonly used in the definitions of “optic disc tilt” and “torsion” as well as the clinical “gamma” and “delta” zones, its use has also contributed to the lack of anatomically consistent OCT definitions for these terms.3–6,21,22\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) The clinical “optic disc” and “peripapillary” regions are defined relative to the clinical disc margin (see Supplemental Figure 1). (B) We propose that OCT examination of the ONH tissues should be organized relative to the OCT-detected Bruch’s membrane opening (BMO) and neural canal. (C) OCT-radial B-scan from the location depicted by the green line in Panel B. (D) We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axon bundles achieve the retrolaminar orbital optic nerve.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We propose these terms so as to distinguish OCT ONH anatomic terminology from the clinical terms optic disc, papilla, and peri-papillary which have no consistent histologic or OCT-detectable anatomic foundation. (see Supplemental Figure 1)We have previously defined23,24 the ONH anatomically and morphologically (Figures 1 and 2 and Supplemental Figure 1) to include the tissues within the neural canal and those immediately adjacent to it.11,12,23 The ONH tissues thus include not just the retinal ganglion cell (RGC) axons, their associated glia and vasculature and the lamina cribrosa (within the neural canal), but also the scleral flange23–26, the pNC-sclera, choroid and retina, the immediate retrolaminar orbital optic nerve, the dural and pial sheath insertions and the medial portion of the inferior oblique muscle insertion (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For this study the scleral flange opening (SFO) was manually segmented either “geometrically” when identifiable (Panels B2 and C2, see Methods) or, when not geometrically identifiable, estimated visually by projecting the anterior laminar surface through the neural canal wall (Panel A2, see methods). (A3 – C3) Existing BMO and ASCO segmentations in combination with the segmented SFO points were used to define the externally oblique CBT (EOCBT) and Exposed Scleral Flange (ESF) which were parameterized within BMO reference plane as shown in Figure 5.We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axons achieve the orbital optic nerve (Figures 1 and 2 and Supplemental Figure 1).7,10,12,23,27 The pre-scleral neural canal extends from Bruch’s membrane opening, (BMO), through the anterior scleral canal opening, (ASCO) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It consists of the choroidal border tissues (CBT) which are known histologically as the border tissues of Elschnig.27–29 The scleral portion of the neural canal extends from the ASCO through the scleral flange opening (SFO), (when present - see Methods and Figures 1–4), ending at the posterior scleral canal opening (PSCO) which can be identified histologically23,30 but is, at present, only inconsistently visualized by OCT (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "All eyes are shown in right eye orientation.In previous 3D-histomorphometric monkey studies,23,24 we defined the scleral flange to be the portion of the pNC-sclera that was “internal” to the PSCO (Figure 2.) In separate histologic studies in post-mortem human eyes,25,26 Jonas defined the scleral flange to be the portion of the pNC-sclera that was “central “or “internal” to the dural sheath insertion.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Second, scleral flange morphology is influenced by the insertion of the dural sheath into the pNC sclera which adds substantial thickness to the posterior sclera peripheral to the flange.25,26\nIn our recent study,12 we manually segmented BMO, the ASCO and the OCT-determined scleral flange opening (SFO), (when present), in 362 non-highly myopic healthy eyes, so as to report the prevalence, magnitude and Foveal-BMO (FoBMO) location of a new, OCT-defined, ONH region - the “exposed neural canal” (ENC) region (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Pre-scleral and scleral flange neural canal anatomy projected onto the fundus photo of study eye Hi-Myo-GL-29, (also shown in Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figures 1–4 provide illustrations and explanations of the anatomic terms associated with the OCT neural canal and scleral flange.11,12\nFigure 4 illustrates OCT examples of ENC regions and sub-regions within representative Non-Hi-Myo-Healthy and Hi-Myo eyes of this study.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "7,8,68,69\nIn eyes with an ESF region, the SFO,12 was anatomically defined to be the transition between the anterior and internal surfaces of the scleral flange (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was manually segmented “geometrically” (Figure 2, Panels B2 and C2) when the transition from the “anterior” to the “internal” scleral flange surfaces (Figure 2, Panel C2), was acute enough to be visually identified.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes where the transition was not visually discernible (see Discussion), the operator “estimated” the SFO by visually projecting the anterior laminar surface through the neural canal wall (Figure 2, Panel A2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In all instances, and for all segmentations, the operator was able to inspect adjacent B-scans on either side of the B-scan in question to inform their final SFO segmentation choice within a given B-scan.Sectoral ENC, EOCBT and ESF Measurements (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See Figure 3 for the 30° sectoral acronym names shown in Panel E.For each eye, segmented BMO, ASCO and SFO points along with BMO centroid (the centroid of the segmented BMO points) were projected to the BMO reference plane (Figure 5A – 5D) for re-sampled measurement within 30° sectors (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Within each sector, four equally-spaced re-sampling lines were used to measure the radial extent (magnitude) of the EOCBT, ESF and ENC (the sum of the two) regions (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See our previous report12 for a detailed explanation.BMO, ASCO, SFO and Neural Canal Minimum Cross-Sectional Area (NCMCA) Size and Shape Measurements (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Bruch’s membrane opening (BMO), (B) the anterior scleral canal opening (ASCO), (C) the scleral flange opening (SFO) (see Methods) and (D) Neural Canal Minimum Cross-Sectional area (NCMCA) which is an estimate of the smallest dimension of the pre-scleral neural canal through which the retinal ganglion cell axons pass (see Methods and Supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NCMCA (Figure 6 and Supplemental Figure 2)7 estimates the smallest opening that the RGC axons pass through as they move through the pre-scleral neural canal.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The size and ovality index of NCMCA was computed within the projection plane, using the methods described for BMO, the ASCO and the SFO, above.BMO/ASCO Offset Magnitude. (Figure 7 - left).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Subsequently, a best-fit ellipse was fitted to calculate the centroids of both the BMO and ASCO.70,71 The magnitude of BMO/ASCO offset was established by projecting the vector connecting the ASCO and BMO centroids to the BMO reference plane (the BMO/ASCO centroid vector), and transposing it from the projected ASCO centroid to the BMO centroid.BMO/SFO Offset Magnitude (Figure 7 - right).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Global and FoBMO 30° BMO-MRW and pNC-RNFLT data were generated as previously described.12,64 pNC-CT measurements in FoBMO 30⁰ sectors were generated from the 24 radial B-scans, as previously described8,11,12,69 (Supplemental Figure 3). pNC-CT data at the 100, 300, 500 and 700 μm measurement points were represented in microns and as their age-corrected, normative range percentile for each FoBMO sector of each study eye.Subdivision of Study eyes into Hi-ESF and Non-Hi-ESF subgroups.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ENC region sectoral magnitude is greatest and pNC-RNFLT and pNC-CT are thinnest in the inferior-temporal sectors of both the Hi-Myo and Non-Hi-Myo-Healthy eyes (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 4 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the inferior temporal thinning shown in the pNC-CT 300 data included above.The longer sectoral length of the ENC regions and the thinner sectoral thickness of pNC-RNFLT and pNC-CT in the Hi-Myo versus the Non-Hi-Myo-Healthy eyes are also most pronounced within the inferior-temporal sectors.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT at the 300 μm measurement point (pNC-CT 300) data shown in Figure 8.Differences between the Hi-Myo Hi-ESF versus the Non-Hi-Myo-Healthy Hi-ESF eyes (Tables 1–3).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Among the Hi-Myo-GL eyes, while visual field loss was greater in the Hi-ESF compared to the Non-Hi-ESF eyes, this difference did not achieve significance.ENC region sectoral magnitude as well as pNC-RNFLT and pNC-CT are decreased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel), see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 5 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the pNC-CT 300 data included above.Against expectation, while in both groups the inferior temporal sectors demonstrate the highest ENC regional magnitudes and the thinnest pNC-RNFLT and pNC-CT, the sectoral magnitudes of each ENC region and sub-region were decreased rather than increased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (see Discussion).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT-300 data shown in Figure 9.Ocular and Demographic Factors associated with the ENC, EOCBT and ESF regions of the Hi-Myo eyes (Table 7).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "To further clarify these findings, we performed additional univariable and multivariable association studies in “All Study” eyes (Supplemental Table 4, n=484 eyes spanning the full spectrum of axial length and spherical equivalent) and “All Hi-ESF eyes (Supplemental Figure 5, n=160 eyes also spanning the full spectrum of both parameters).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, as would be expected morphologically, (Figure 10), BMO/ASCO offset magnitude consistently predicted the magnitude of the ENC region (except for the “All Study Eye” analysis) and EOCBT region.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "See Table 7 and Supplemental Tables 4 and 5 for the expanded Univariable and Multivariable association data that are summarized herein).Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(Left Panel) The existing exposed neural canal (ENC) region from the 48 year old Hi-Myo-GL-29 example eye from Figure 4 is used to create a “Proposed Longitudinal Change” scenario (Left Middle Panels - top-to-bottom) in which CBT “externalization” and “insertion migration” away from the post-embryonic ASCO creates an ESF region and a geometrically identifiable SFO that is separate from the ASCO.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In this report we have simplified the term to SFO for clarity and now propose that in any cross-sectional OCT images of post-embryonic eyes, (i.e., at any post-embryonic point in life at which the eye is imaged), at radial ONH locations where an SFO point can be identified separate from an ASCO point, the SFO point is the “original” (i.e., “post-embryonic development” or “pre-myopic neural canal remodeling”) entrance to the scleral flange portion of the neural canal.12 (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Likewise, the SFO as an opening, represents the “entrance” to the scleral flange portion of the neural canal at the end of neural canal embryonic development, (though its size, shape and planarity may also have been altered by postembryonic remodeling).12 In this same construct, the ASCO, as detected in the same images, represents the “entrance” to the scleral flange portion of the neural canal after whatever post-embryonic remodeling of the CBT (Figure 10)13 has occurred.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 10, (modified from our previous report),12 uses the Hi-Myo-GL-29 eye from Figure 4 to create a “Proposed Longitudinal Change” scenario in which CBT “externalization” and “insertion migration” away from the “embryonic” entrance to the scleral flange portion of the neural canal creates an ESF region as well as an ASCO point that is separate from a geometrically identifiable SFO point.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 10 also includes a second, “Alternative Longitudinal Change” scenario, in which the CBT become externalized and then elongate progressively without losing their insertion into the post-embryonic ASCO point creating an ENC region that consists entirely of EOCBT.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 11 illustrates how increased peri-neural canal scleral bowing (pNC-SB) and increased neural canal scleral flange bowing (neither of which having been reported in this study) in the Hi-Myo-GL eyes may have increased the “axial” orientation of the scleral flange and in so doing reduced the “transverse extent” of the exposed neural canal (ENC) regions in the Hi-Myo-GL eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "We have previously reported that pNC-SB is greater in the Halifax subset of the Hi-Myo-GL eyes (see methods) compared to the Halifax Hi-Myo-Healthy eyes of this study.11 In a manuscript in preparation, we will measure both neural canal scleral flange bowing (Supplemental Figure 6)11 and “running length” (rather than) “projected length” measures of each ENC region in an expanded group of Hi-Myo-GL versus Hi-Myo-Healthy eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Other Acknowledgments\nAnuwat Jiravarnsirikul and Hongli Yang contributed equally to this work.Abbreviations/Acronyms:\n\nASCO\nanterior sclera canal opening\nBM\nBruch’s Membrane\nBMO\nBruch’s membrane opening\nCBT\nChoroidal Border Tissues – previously referred to by their histologic name (“Border tissues of Elschnig”)\nCCT\ncentral corneal thickness\nCDM\nclinical disc margin\nCSF\nCerebrospinal Fluid\nDIGS\nDiagnostic Innovations in Glaucoma Study\nENC\nexposed Neural Canal\nEOCBT\nExternally Oblique CBT\nESF\nExposed Scleral Flange\nFDA\nFood and Drug Administration\nFoBMO\nFoveal-BMO\nGHT\nGlaucoma Hemifield Test\nHi-ESF\nStudy Eyes in which the ESF region is ≥ 100 μms in at least one sector\nHi-Myo\nHighly myopic eyes\nHi-Myo-Healthy\nHighly myopic healthy eyes\nHi-Myo-GL\nHighly myopic eyes with glaucoma\nIOCBT\nInternally Oblique Choroidal Border Tissues\nIOP\nIntraocular pressure\nMD\nMean Deviation\nMRW\nMinimum Rim Width\nNC\nNeural Canal\nNCMCA\nNeural Canal Minimum Cross-Sectional Area\nNCSFB\nneural canal scleral flange bowing\nNon-Hi-ESF\nStudy eyes in which the ESF region is < 100 μms in all sectors\nNon-Hi-Myo-Healthy\nNon-highly myopic healthy eyes\nPSCO\nPosterior Scleral Canal Opening (Not segmented in this study)\nOCT\noptical coherence tomography\nONH\noptic nerve head\npNC\nperineural canal\npNC-CT\nperineural canal choroidal thickness\npNC-SB\nperineural canal scleral bowing\nRNFL\nretinal nerve fiber layer\nRNFLT\nRNFL thickness\nRPE\nRetinal Pigment Epithelium\nSector\nONH FoBMO 30° (clock-hour) sectors (see Figure 2, Panel (A))\nSFO\nScleral Flange Opening\nSD\nstandard deviation\nSE\nspherical equivalent\nUCSD\nUniversity of California, San Diego\nFootnotes\nPublisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In their absence, the field has only recently begun to build an OCT-based conceptual framework for parameterizing longitudinal “myopic” ONH remodeling.13–16\nIn recent publications,11,12 we have introduced OCT-defined, ONH neural canal and peri-neural canal (pNC) tissue terminology (Figure 1) to identify and distinguish OCT ONH terminology, (which we argue should be based on OCT-detected anatomic landmarks) from the clinical terms “optic disc” and “peripapillary” because these terms, being based on clinical photographic and clinical biomicroscopic assignment of the clinical disc margin, have no consistent OCT-detectable anatomic foundation in the human eye.17,18 Having no consistent anatomic foundation, the clinical disc margin is inconsistently assigned by clinicians18–20 (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Because the clinical disc margin is commonly used in the definitions of “optic disc tilt” and “torsion” as well as the clinical “gamma” and “delta” zones, its use has also contributed to the lack of anatomically consistent OCT definitions for these terms.3–6,21,22\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) The clinical “optic disc” and “peripapillary” regions are defined relative to the clinical disc margin (see Supplemental Figure 1). (B) We propose that OCT examination of the ONH tissues should be organized relative to the OCT-detected Bruch’s membrane opening (BMO) and neural canal. (C) OCT-radial B-scan from the location depicted by the green line in Panel B. (D) We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axon bundles achieve the retrolaminar orbital optic nerve.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We propose these terms so as to distinguish OCT ONH anatomic terminology from the clinical terms optic disc, papilla, and peri-papillary which have no consistent histologic or OCT-detectable anatomic foundation. (see Supplemental Figure 1)We have previously defined23,24 the ONH anatomically and morphologically (Figures 1 and 2 and Supplemental Figure 1) to include the tissues within the neural canal and those immediately adjacent to it.11,12,23 The ONH tissues thus include not just the retinal ganglion cell (RGC) axons, their associated glia and vasculature and the lamina cribrosa (within the neural canal), but also the scleral flange23–26, the pNC-sclera, choroid and retina, the immediate retrolaminar orbital optic nerve, the dural and pial sheath insertions and the medial portion of the inferior oblique muscle insertion (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For this study the scleral flange opening (SFO) was manually segmented either “geometrically” when identifiable (Panels B2 and C2, see Methods) or, when not geometrically identifiable, estimated visually by projecting the anterior laminar surface through the neural canal wall (Panel A2, see methods). (A3 – C3) Existing BMO and ASCO segmentations in combination with the segmented SFO points were used to define the externally oblique CBT (EOCBT) and Exposed Scleral Flange (ESF) which were parameterized within BMO reference plane as shown in Figure 5.We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axons achieve the orbital optic nerve (Figures 1 and 2 and Supplemental Figure 1).7,10,12,23,27 The pre-scleral neural canal extends from Bruch’s membrane opening, (BMO), through the anterior scleral canal opening, (ASCO) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It consists of the choroidal border tissues (CBT) which are known histologically as the border tissues of Elschnig.27–29 The scleral portion of the neural canal extends from the ASCO through the scleral flange opening (SFO), (when present - see Methods and Figures 1–4), ending at the posterior scleral canal opening (PSCO) which can be identified histologically23,30 but is, at present, only inconsistently visualized by OCT (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "All eyes are shown in right eye orientation.In previous 3D-histomorphometric monkey studies,23,24 we defined the scleral flange to be the portion of the pNC-sclera that was “internal” to the PSCO (Figure 2.) In separate histologic studies in post-mortem human eyes,25,26 Jonas defined the scleral flange to be the portion of the pNC-sclera that was “central “or “internal” to the dural sheath insertion.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Second, scleral flange morphology is influenced by the insertion of the dural sheath into the pNC sclera which adds substantial thickness to the posterior sclera peripheral to the flange.25,26\nIn our recent study,12 we manually segmented BMO, the ASCO and the OCT-determined scleral flange opening (SFO), (when present), in 362 non-highly myopic healthy eyes, so as to report the prevalence, magnitude and Foveal-BMO (FoBMO) location of a new, OCT-defined, ONH region - the “exposed neural canal” (ENC) region (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Pre-scleral and scleral flange neural canal anatomy projected onto the fundus photo of study eye Hi-Myo-GL-29, (also shown in Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figures 1–4 provide illustrations and explanations of the anatomic terms associated with the OCT neural canal and scleral flange.11,12\nFigure 4 illustrates OCT examples of ENC regions and sub-regions within representative Non-Hi-Myo-Healthy and Hi-Myo eyes of this study.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "7,8,68,69\nIn eyes with an ESF region, the SFO,12 was anatomically defined to be the transition between the anterior and internal surfaces of the scleral flange (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was manually segmented “geometrically” (Figure 2, Panels B2 and C2) when the transition from the “anterior” to the “internal” scleral flange surfaces (Figure 2, Panel C2), was acute enough to be visually identified.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes where the transition was not visually discernible (see Discussion), the operator “estimated” the SFO by visually projecting the anterior laminar surface through the neural canal wall (Figure 2, Panel A2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In all instances, and for all segmentations, the operator was able to inspect adjacent B-scans on either side of the B-scan in question to inform their final SFO segmentation choice within a given B-scan.Sectoral ENC, EOCBT and ESF Measurements (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See Figure 3 for the 30° sectoral acronym names shown in Panel E.For each eye, segmented BMO, ASCO and SFO points along with BMO centroid (the centroid of the segmented BMO points) were projected to the BMO reference plane (Figure 5A – 5D) for re-sampled measurement within 30° sectors (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Within each sector, four equally-spaced re-sampling lines were used to measure the radial extent (magnitude) of the EOCBT, ESF and ENC (the sum of the two) regions (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See our previous report12 for a detailed explanation.BMO, ASCO, SFO and Neural Canal Minimum Cross-Sectional Area (NCMCA) Size and Shape Measurements (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Bruch’s membrane opening (BMO), (B) the anterior scleral canal opening (ASCO), (C) the scleral flange opening (SFO) (see Methods) and (D) Neural Canal Minimum Cross-Sectional area (NCMCA) which is an estimate of the smallest dimension of the pre-scleral neural canal through which the retinal ganglion cell axons pass (see Methods and Supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NCMCA (Figure 6 and Supplemental Figure 2)7 estimates the smallest opening that the RGC axons pass through as they move through the pre-scleral neural canal.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The size and ovality index of NCMCA was computed within the projection plane, using the methods described for BMO, the ASCO and the SFO, above.BMO/ASCO Offset Magnitude. (Figure 7 - left).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Subsequently, a best-fit ellipse was fitted to calculate the centroids of both the BMO and ASCO.70,71 The magnitude of BMO/ASCO offset was established by projecting the vector connecting the ASCO and BMO centroids to the BMO reference plane (the BMO/ASCO centroid vector), and transposing it from the projected ASCO centroid to the BMO centroid.BMO/SFO Offset Magnitude (Figure 7 - right).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Global and FoBMO 30° BMO-MRW and pNC-RNFLT data were generated as previously described.12,64 pNC-CT measurements in FoBMO 30⁰ sectors were generated from the 24 radial B-scans, as previously described8,11,12,69 (Supplemental Figure 3). pNC-CT data at the 100, 300, 500 and 700 μm measurement points were represented in microns and as their age-corrected, normative range percentile for each FoBMO sector of each study eye.Subdivision of Study eyes into Hi-ESF and Non-Hi-ESF subgroups.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ENC region sectoral magnitude is greatest and pNC-RNFLT and pNC-CT are thinnest in the inferior-temporal sectors of both the Hi-Myo and Non-Hi-Myo-Healthy eyes (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 4 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the inferior temporal thinning shown in the pNC-CT 300 data included above.The longer sectoral length of the ENC regions and the thinner sectoral thickness of pNC-RNFLT and pNC-CT in the Hi-Myo versus the Non-Hi-Myo-Healthy eyes are also most pronounced within the inferior-temporal sectors.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT at the 300 μm measurement point (pNC-CT 300) data shown in Figure 8.Differences between the Hi-Myo Hi-ESF versus the Non-Hi-Myo-Healthy Hi-ESF eyes (Tables 1–3).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Among the Hi-Myo-GL eyes, while visual field loss was greater in the Hi-ESF compared to the Non-Hi-ESF eyes, this difference did not achieve significance.ENC region sectoral magnitude as well as pNC-RNFLT and pNC-CT are decreased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel), see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 5 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the pNC-CT 300 data included above.Against expectation, while in both groups the inferior temporal sectors demonstrate the highest ENC regional magnitudes and the thinnest pNC-RNFLT and pNC-CT, the sectoral magnitudes of each ENC region and sub-region were decreased rather than increased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (see Discussion).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT-300 data shown in Figure 9.Ocular and Demographic Factors associated with the ENC, EOCBT and ESF regions of the Hi-Myo eyes (Table 7).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "To further clarify these findings, we performed additional univariable and multivariable association studies in “All Study” eyes (Supplemental Table 4, n=484 eyes spanning the full spectrum of axial length and spherical equivalent) and “All Hi-ESF eyes (Supplemental Figure 5, n=160 eyes also spanning the full spectrum of both parameters).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, as would be expected morphologically, (Figure 10), BMO/ASCO offset magnitude consistently predicted the magnitude of the ENC region (except for the “All Study Eye” analysis) and EOCBT region.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "See Table 7 and Supplemental Tables 4 and 5 for the expanded Univariable and Multivariable association data that are summarized herein).Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(Left Panel) The existing exposed neural canal (ENC) region from the 48 year old Hi-Myo-GL-29 example eye from Figure 4 is used to create a “Proposed Longitudinal Change” scenario (Left Middle Panels - top-to-bottom) in which CBT “externalization” and “insertion migration” away from the post-embryonic ASCO creates an ESF region and a geometrically identifiable SFO that is separate from the ASCO.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In this report we have simplified the term to SFO for clarity and now propose that in any cross-sectional OCT images of post-embryonic eyes, (i.e., at any post-embryonic point in life at which the eye is imaged), at radial ONH locations where an SFO point can be identified separate from an ASCO point, the SFO point is the “original” (i.e., “post-embryonic development” or “pre-myopic neural canal remodeling”) entrance to the scleral flange portion of the neural canal.12 (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Likewise, the SFO as an opening, represents the “entrance” to the scleral flange portion of the neural canal at the end of neural canal embryonic development, (though its size, shape and planarity may also have been altered by postembryonic remodeling).12 In this same construct, the ASCO, as detected in the same images, represents the “entrance” to the scleral flange portion of the neural canal after whatever post-embryonic remodeling of the CBT (Figure 10)13 has occurred.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 10, (modified from our previous report),12 uses the Hi-Myo-GL-29 eye from Figure 4 to create a “Proposed Longitudinal Change” scenario in which CBT “externalization” and “insertion migration” away from the “embryonic” entrance to the scleral flange portion of the neural canal creates an ESF region as well as an ASCO point that is separate from a geometrically identifiable SFO point.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 10 also includes a second, “Alternative Longitudinal Change” scenario, in which the CBT become externalized and then elongate progressively without losing their insertion into the post-embryonic ASCO point creating an ENC region that consists entirely of EOCBT.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 11 illustrates how increased peri-neural canal scleral bowing (pNC-SB) and increased neural canal scleral flange bowing (neither of which having been reported in this study) in the Hi-Myo-GL eyes may have increased the “axial” orientation of the scleral flange and in so doing reduced the “transverse extent” of the exposed neural canal (ENC) regions in the Hi-Myo-GL eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "We have previously reported that pNC-SB is greater in the Halifax subset of the Hi-Myo-GL eyes (see methods) compared to the Halifax Hi-Myo-Healthy eyes of this study.11 In a manuscript in preparation, we will measure both neural canal scleral flange bowing (Supplemental Figure 6)11 and “running length” (rather than) “projected length” measures of each ENC region in an expanded group of Hi-Myo-GL versus Hi-Myo-Healthy eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Other Acknowledgments\nAnuwat Jiravarnsirikul and Hongli Yang contributed equally to this work.Abbreviations/Acronyms:\n\nASCO\nanterior sclera canal opening\nBM\nBruch’s Membrane\nBMO\nBruch’s membrane opening\nCBT\nChoroidal Border Tissues – previously referred to by their histologic name (“Border tissues of Elschnig”)\nCCT\ncentral corneal thickness\nCDM\nclinical disc margin\nCSF\nCerebrospinal Fluid\nDIGS\nDiagnostic Innovations in Glaucoma Study\nENC\nexposed Neural Canal\nEOCBT\nExternally Oblique CBT\nESF\nExposed Scleral Flange\nFDA\nFood and Drug Administration\nFoBMO\nFoveal-BMO\nGHT\nGlaucoma Hemifield Test\nHi-ESF\nStudy Eyes in which the ESF region is ≥ 100 μms in at least one sector\nHi-Myo\nHighly myopic eyes\nHi-Myo-Healthy\nHighly myopic healthy eyes\nHi-Myo-GL\nHighly myopic eyes with glaucoma\nIOCBT\nInternally Oblique Choroidal Border Tissues\nIOP\nIntraocular pressure\nMD\nMean Deviation\nMRW\nMinimum Rim Width\nNC\nNeural Canal\nNCMCA\nNeural Canal Minimum Cross-Sectional Area\nNCSFB\nneural canal scleral flange bowing\nNon-Hi-ESF\nStudy eyes in which the ESF region is < 100 μms in all sectors\nNon-Hi-Myo-Healthy\nNon-highly myopic healthy eyes\nPSCO\nPosterior Scleral Canal Opening (Not segmented in this study)\nOCT\noptical coherence tomography\nONH\noptic nerve head\npNC\nperineural canal\npNC-CT\nperineural canal choroidal thickness\npNC-SB\nperineural canal scleral bowing\nRNFL\nretinal nerve fiber layer\nRNFLT\nRNFL thickness\nRPE\nRetinal Pigment Epithelium\nSector\nONH FoBMO 30° (clock-hour) sectors (see Figure 2, Panel (A))\nSFO\nScleral Flange Opening\nSD\nstandard deviation\nSE\nspherical equivalent\nUCSD\nUniversity of California, San Diego\nFootnotes\nPublisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In their absence, the field has only recently begun to build an OCT-based conceptual framework for parameterizing longitudinal “myopic” ONH remodeling.13–16\nIn recent publications,11,12 we have introduced OCT-defined, ONH neural canal and peri-neural canal (pNC) tissue terminology (Figure 1) to identify and distinguish OCT ONH terminology, (which we argue should be based on OCT-detected anatomic landmarks) from the clinical terms “optic disc” and “peripapillary” because these terms, being based on clinical photographic and clinical biomicroscopic assignment of the clinical disc margin, have no consistent OCT-detectable anatomic foundation in the human eye.17,18 Having no consistent anatomic foundation, the clinical disc margin is inconsistently assigned by clinicians18–20 (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Because the clinical disc margin is commonly used in the definitions of “optic disc tilt” and “torsion” as well as the clinical “gamma” and “delta” zones, its use has also contributed to the lack of anatomically consistent OCT definitions for these terms.3–6,21,22\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) The clinical “optic disc” and “peripapillary” regions are defined relative to the clinical disc margin (see Supplemental Figure 1). (B) We propose that OCT examination of the ONH tissues should be organized relative to the OCT-detected Bruch’s membrane opening (BMO) and neural canal. (C) OCT-radial B-scan from the location depicted by the green line in Panel B. (D) We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axon bundles achieve the retrolaminar orbital optic nerve.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We propose these terms so as to distinguish OCT ONH anatomic terminology from the clinical terms optic disc, papilla, and peri-papillary which have no consistent histologic or OCT-detectable anatomic foundation. (see Supplemental Figure 1)We have previously defined23,24 the ONH anatomically and morphologically (Figures 1 and 2 and Supplemental Figure 1) to include the tissues within the neural canal and those immediately adjacent to it.11,12,23 The ONH tissues thus include not just the retinal ganglion cell (RGC) axons, their associated glia and vasculature and the lamina cribrosa (within the neural canal), but also the scleral flange23–26, the pNC-sclera, choroid and retina, the immediate retrolaminar orbital optic nerve, the dural and pial sheath insertions and the medial portion of the inferior oblique muscle insertion (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For this study the scleral flange opening (SFO) was manually segmented either “geometrically” when identifiable (Panels B2 and C2, see Methods) or, when not geometrically identifiable, estimated visually by projecting the anterior laminar surface through the neural canal wall (Panel A2, see methods). (A3 – C3) Existing BMO and ASCO segmentations in combination with the segmented SFO points were used to define the externally oblique CBT (EOCBT) and Exposed Scleral Flange (ESF) which were parameterized within BMO reference plane as shown in Figure 5.We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axons achieve the orbital optic nerve (Figures 1 and 2 and Supplemental Figure 1).7,10,12,23,27 The pre-scleral neural canal extends from Bruch’s membrane opening, (BMO), through the anterior scleral canal opening, (ASCO) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It consists of the choroidal border tissues (CBT) which are known histologically as the border tissues of Elschnig.27–29 The scleral portion of the neural canal extends from the ASCO through the scleral flange opening (SFO), (when present - see Methods and Figures 1–4), ending at the posterior scleral canal opening (PSCO) which can be identified histologically23,30 but is, at present, only inconsistently visualized by OCT (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "All eyes are shown in right eye orientation.In previous 3D-histomorphometric monkey studies,23,24 we defined the scleral flange to be the portion of the pNC-sclera that was “internal” to the PSCO (Figure 2.) In separate histologic studies in post-mortem human eyes,25,26 Jonas defined the scleral flange to be the portion of the pNC-sclera that was “central “or “internal” to the dural sheath insertion.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Second, scleral flange morphology is influenced by the insertion of the dural sheath into the pNC sclera which adds substantial thickness to the posterior sclera peripheral to the flange.25,26\nIn our recent study,12 we manually segmented BMO, the ASCO and the OCT-determined scleral flange opening (SFO), (when present), in 362 non-highly myopic healthy eyes, so as to report the prevalence, magnitude and Foveal-BMO (FoBMO) location of a new, OCT-defined, ONH region - the “exposed neural canal” (ENC) region (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Pre-scleral and scleral flange neural canal anatomy projected onto the fundus photo of study eye Hi-Myo-GL-29, (also shown in Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figures 1–4 provide illustrations and explanations of the anatomic terms associated with the OCT neural canal and scleral flange.11,12\nFigure 4 illustrates OCT examples of ENC regions and sub-regions within representative Non-Hi-Myo-Healthy and Hi-Myo eyes of this study.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "7,8,68,69\nIn eyes with an ESF region, the SFO,12 was anatomically defined to be the transition between the anterior and internal surfaces of the scleral flange (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was manually segmented “geometrically” (Figure 2, Panels B2 and C2) when the transition from the “anterior” to the “internal” scleral flange surfaces (Figure 2, Panel C2), was acute enough to be visually identified.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes where the transition was not visually discernible (see Discussion), the operator “estimated” the SFO by visually projecting the anterior laminar surface through the neural canal wall (Figure 2, Panel A2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In all instances, and for all segmentations, the operator was able to inspect adjacent B-scans on either side of the B-scan in question to inform their final SFO segmentation choice within a given B-scan.Sectoral ENC, EOCBT and ESF Measurements (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See Figure 3 for the 30° sectoral acronym names shown in Panel E.For each eye, segmented BMO, ASCO and SFO points along with BMO centroid (the centroid of the segmented BMO points) were projected to the BMO reference plane (Figure 5A – 5D) for re-sampled measurement within 30° sectors (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Within each sector, four equally-spaced re-sampling lines were used to measure the radial extent (magnitude) of the EOCBT, ESF and ENC (the sum of the two) regions (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See our previous report12 for a detailed explanation.BMO, ASCO, SFO and Neural Canal Minimum Cross-Sectional Area (NCMCA) Size and Shape Measurements (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Bruch’s membrane opening (BMO), (B) the anterior scleral canal opening (ASCO), (C) the scleral flange opening (SFO) (see Methods) and (D) Neural Canal Minimum Cross-Sectional area (NCMCA) which is an estimate of the smallest dimension of the pre-scleral neural canal through which the retinal ganglion cell axons pass (see Methods and Supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NCMCA (Figure 6 and Supplemental Figure 2)7 estimates the smallest opening that the RGC axons pass through as they move through the pre-scleral neural canal.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The size and ovality index of NCMCA was computed within the projection plane, using the methods described for BMO, the ASCO and the SFO, above.BMO/ASCO Offset Magnitude. (Figure 7 - left).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Subsequently, a best-fit ellipse was fitted to calculate the centroids of both the BMO and ASCO.70,71 The magnitude of BMO/ASCO offset was established by projecting the vector connecting the ASCO and BMO centroids to the BMO reference plane (the BMO/ASCO centroid vector), and transposing it from the projected ASCO centroid to the BMO centroid.BMO/SFO Offset Magnitude (Figure 7 - right).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Global and FoBMO 30° BMO-MRW and pNC-RNFLT data were generated as previously described.12,64 pNC-CT measurements in FoBMO 30⁰ sectors were generated from the 24 radial B-scans, as previously described8,11,12,69 (Supplemental Figure 3). pNC-CT data at the 100, 300, 500 and 700 μm measurement points were represented in microns and as their age-corrected, normative range percentile for each FoBMO sector of each study eye.Subdivision of Study eyes into Hi-ESF and Non-Hi-ESF subgroups.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ENC region sectoral magnitude is greatest and pNC-RNFLT and pNC-CT are thinnest in the inferior-temporal sectors of both the Hi-Myo and Non-Hi-Myo-Healthy eyes (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 4 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the inferior temporal thinning shown in the pNC-CT 300 data included above.The longer sectoral length of the ENC regions and the thinner sectoral thickness of pNC-RNFLT and pNC-CT in the Hi-Myo versus the Non-Hi-Myo-Healthy eyes are also most pronounced within the inferior-temporal sectors.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT at the 300 μm measurement point (pNC-CT 300) data shown in Figure 8.Differences between the Hi-Myo Hi-ESF versus the Non-Hi-Myo-Healthy Hi-ESF eyes (Tables 1–3).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Among the Hi-Myo-GL eyes, while visual field loss was greater in the Hi-ESF compared to the Non-Hi-ESF eyes, this difference did not achieve significance.ENC region sectoral magnitude as well as pNC-RNFLT and pNC-CT are decreased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel), see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 5 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the pNC-CT 300 data included above.Against expectation, while in both groups the inferior temporal sectors demonstrate the highest ENC regional magnitudes and the thinnest pNC-RNFLT and pNC-CT, the sectoral magnitudes of each ENC region and sub-region were decreased rather than increased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (see Discussion).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT-300 data shown in Figure 9.Ocular and Demographic Factors associated with the ENC, EOCBT and ESF regions of the Hi-Myo eyes (Table 7).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "To further clarify these findings, we performed additional univariable and multivariable association studies in “All Study” eyes (Supplemental Table 4, n=484 eyes spanning the full spectrum of axial length and spherical equivalent) and “All Hi-ESF eyes (Supplemental Figure 5, n=160 eyes also spanning the full spectrum of both parameters).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, as would be expected morphologically, (Figure 10), BMO/ASCO offset magnitude consistently predicted the magnitude of the ENC region (except for the “All Study Eye” analysis) and EOCBT region.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "See Table 7 and Supplemental Tables 4 and 5 for the expanded Univariable and Multivariable association data that are summarized herein).Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(Left Panel) The existing exposed neural canal (ENC) region from the 48 year old Hi-Myo-GL-29 example eye from Figure 4 is used to create a “Proposed Longitudinal Change” scenario (Left Middle Panels - top-to-bottom) in which CBT “externalization” and “insertion migration” away from the post-embryonic ASCO creates an ESF region and a geometrically identifiable SFO that is separate from the ASCO.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In this report we have simplified the term to SFO for clarity and now propose that in any cross-sectional OCT images of post-embryonic eyes, (i.e., at any post-embryonic point in life at which the eye is imaged), at radial ONH locations where an SFO point can be identified separate from an ASCO point, the SFO point is the “original” (i.e., “post-embryonic development” or “pre-myopic neural canal remodeling”) entrance to the scleral flange portion of the neural canal.12 (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Likewise, the SFO as an opening, represents the “entrance” to the scleral flange portion of the neural canal at the end of neural canal embryonic development, (though its size, shape and planarity may also have been altered by postembryonic remodeling).12 In this same construct, the ASCO, as detected in the same images, represents the “entrance” to the scleral flange portion of the neural canal after whatever post-embryonic remodeling of the CBT (Figure 10)13 has occurred.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 10, (modified from our previous report),12 uses the Hi-Myo-GL-29 eye from Figure 4 to create a “Proposed Longitudinal Change” scenario in which CBT “externalization” and “insertion migration” away from the “embryonic” entrance to the scleral flange portion of the neural canal creates an ESF region as well as an ASCO point that is separate from a geometrically identifiable SFO point.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 10 also includes a second, “Alternative Longitudinal Change” scenario, in which the CBT become externalized and then elongate progressively without losing their insertion into the post-embryonic ASCO point creating an ENC region that consists entirely of EOCBT.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 11 illustrates how increased peri-neural canal scleral bowing (pNC-SB) and increased neural canal scleral flange bowing (neither of which having been reported in this study) in the Hi-Myo-GL eyes may have increased the “axial” orientation of the scleral flange and in so doing reduced the “transverse extent” of the exposed neural canal (ENC) regions in the Hi-Myo-GL eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "We have previously reported that pNC-SB is greater in the Halifax subset of the Hi-Myo-GL eyes (see methods) compared to the Halifax Hi-Myo-Healthy eyes of this study.11 In a manuscript in preparation, we will measure both neural canal scleral flange bowing (Supplemental Figure 6)11 and “running length” (rather than) “projected length” measures of each ENC region in an expanded group of Hi-Myo-GL versus Hi-Myo-Healthy eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Other Acknowledgments\nAnuwat Jiravarnsirikul and Hongli Yang contributed equally to this work.Abbreviations/Acronyms:\n\nASCO\nanterior sclera canal opening\nBM\nBruch’s Membrane\nBMO\nBruch’s membrane opening\nCBT\nChoroidal Border Tissues – previously referred to by their histologic name (“Border tissues of Elschnig”)\nCCT\ncentral corneal thickness\nCDM\nclinical disc margin\nCSF\nCerebrospinal Fluid\nDIGS\nDiagnostic Innovations in Glaucoma Study\nENC\nexposed Neural Canal\nEOCBT\nExternally Oblique CBT\nESF\nExposed Scleral Flange\nFDA\nFood and Drug Administration\nFoBMO\nFoveal-BMO\nGHT\nGlaucoma Hemifield Test\nHi-ESF\nStudy Eyes in which the ESF region is ≥ 100 μms in at least one sector\nHi-Myo\nHighly myopic eyes\nHi-Myo-Healthy\nHighly myopic healthy eyes\nHi-Myo-GL\nHighly myopic eyes with glaucoma\nIOCBT\nInternally Oblique Choroidal Border Tissues\nIOP\nIntraocular pressure\nMD\nMean Deviation\nMRW\nMinimum Rim Width\nNC\nNeural Canal\nNCMCA\nNeural Canal Minimum Cross-Sectional Area\nNCSFB\nneural canal scleral flange bowing\nNon-Hi-ESF\nStudy eyes in which the ESF region is < 100 μms in all sectors\nNon-Hi-Myo-Healthy\nNon-highly myopic healthy eyes\nPSCO\nPosterior Scleral Canal Opening (Not segmented in this study)\nOCT\noptical coherence tomography\nONH\noptic nerve head\npNC\nperineural canal\npNC-CT\nperineural canal choroidal thickness\npNC-SB\nperineural canal scleral bowing\nRNFL\nretinal nerve fiber layer\nRNFLT\nRNFL thickness\nRPE\nRetinal Pigment Epithelium\nSector\nONH FoBMO 30° (clock-hour) sectors (see Figure 2, Panel (A))\nSFO\nScleral Flange Opening\nSD\nstandard deviation\nSE\nspherical equivalent\nUCSD\nUniversity of California, San Diego\nFootnotes\nPublisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In their absence, the field has only recently begun to build an OCT-based conceptual framework for parameterizing longitudinal “myopic” ONH remodeling.13–16\nIn recent publications,11,12 we have introduced OCT-defined, ONH neural canal and peri-neural canal (pNC) tissue terminology (Figure 1) to identify and distinguish OCT ONH terminology, (which we argue should be based on OCT-detected anatomic landmarks) from the clinical terms “optic disc” and “peripapillary” because these terms, being based on clinical photographic and clinical biomicroscopic assignment of the clinical disc margin, have no consistent OCT-detectable anatomic foundation in the human eye.17,18 Having no consistent anatomic foundation, the clinical disc margin is inconsistently assigned by clinicians18–20 (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Because the clinical disc margin is commonly used in the definitions of “optic disc tilt” and “torsion” as well as the clinical “gamma” and “delta” zones, its use has also contributed to the lack of anatomically consistent OCT definitions for these terms.3–6,21,22\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) The clinical “optic disc” and “peripapillary” regions are defined relative to the clinical disc margin (see Supplemental Figure 1). (B) We propose that OCT examination of the ONH tissues should be organized relative to the OCT-detected Bruch’s membrane opening (BMO) and neural canal. (C) OCT-radial B-scan from the location depicted by the green line in Panel B. (D) We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axon bundles achieve the retrolaminar orbital optic nerve.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We propose these terms so as to distinguish OCT ONH anatomic terminology from the clinical terms optic disc, papilla, and peri-papillary which have no consistent histologic or OCT-detectable anatomic foundation. (see Supplemental Figure 1)We have previously defined23,24 the ONH anatomically and morphologically (Figures 1 and 2 and Supplemental Figure 1) to include the tissues within the neural canal and those immediately adjacent to it.11,12,23 The ONH tissues thus include not just the retinal ganglion cell (RGC) axons, their associated glia and vasculature and the lamina cribrosa (within the neural canal), but also the scleral flange23–26, the pNC-sclera, choroid and retina, the immediate retrolaminar orbital optic nerve, the dural and pial sheath insertions and the medial portion of the inferior oblique muscle insertion (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For this study the scleral flange opening (SFO) was manually segmented either “geometrically” when identifiable (Panels B2 and C2, see Methods) or, when not geometrically identifiable, estimated visually by projecting the anterior laminar surface through the neural canal wall (Panel A2, see methods). (A3 – C3) Existing BMO and ASCO segmentations in combination with the segmented SFO points were used to define the externally oblique CBT (EOCBT) and Exposed Scleral Flange (ESF) which were parameterized within BMO reference plane as shown in Figure 5.We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axons achieve the orbital optic nerve (Figures 1 and 2 and Supplemental Figure 1).7,10,12,23,27 The pre-scleral neural canal extends from Bruch’s membrane opening, (BMO), through the anterior scleral canal opening, (ASCO) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It consists of the choroidal border tissues (CBT) which are known histologically as the border tissues of Elschnig.27–29 The scleral portion of the neural canal extends from the ASCO through the scleral flange opening (SFO), (when present - see Methods and Figures 1–4), ending at the posterior scleral canal opening (PSCO) which can be identified histologically23,30 but is, at present, only inconsistently visualized by OCT (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "All eyes are shown in right eye orientation.In previous 3D-histomorphometric monkey studies,23,24 we defined the scleral flange to be the portion of the pNC-sclera that was “internal” to the PSCO (Figure 2.) In separate histologic studies in post-mortem human eyes,25,26 Jonas defined the scleral flange to be the portion of the pNC-sclera that was “central “or “internal” to the dural sheath insertion.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Second, scleral flange morphology is influenced by the insertion of the dural sheath into the pNC sclera which adds substantial thickness to the posterior sclera peripheral to the flange.25,26\nIn our recent study,12 we manually segmented BMO, the ASCO and the OCT-determined scleral flange opening (SFO), (when present), in 362 non-highly myopic healthy eyes, so as to report the prevalence, magnitude and Foveal-BMO (FoBMO) location of a new, OCT-defined, ONH region - the “exposed neural canal” (ENC) region (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Pre-scleral and scleral flange neural canal anatomy projected onto the fundus photo of study eye Hi-Myo-GL-29, (also shown in Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figures 1–4 provide illustrations and explanations of the anatomic terms associated with the OCT neural canal and scleral flange.11,12\nFigure 4 illustrates OCT examples of ENC regions and sub-regions within representative Non-Hi-Myo-Healthy and Hi-Myo eyes of this study.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "7,8,68,69\nIn eyes with an ESF region, the SFO,12 was anatomically defined to be the transition between the anterior and internal surfaces of the scleral flange (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was manually segmented “geometrically” (Figure 2, Panels B2 and C2) when the transition from the “anterior” to the “internal” scleral flange surfaces (Figure 2, Panel C2), was acute enough to be visually identified.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes where the transition was not visually discernible (see Discussion), the operator “estimated” the SFO by visually projecting the anterior laminar surface through the neural canal wall (Figure 2, Panel A2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In all instances, and for all segmentations, the operator was able to inspect adjacent B-scans on either side of the B-scan in question to inform their final SFO segmentation choice within a given B-scan.Sectoral ENC, EOCBT and ESF Measurements (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See Figure 3 for the 30° sectoral acronym names shown in Panel E.For each eye, segmented BMO, ASCO and SFO points along with BMO centroid (the centroid of the segmented BMO points) were projected to the BMO reference plane (Figure 5A – 5D) for re-sampled measurement within 30° sectors (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Within each sector, four equally-spaced re-sampling lines were used to measure the radial extent (magnitude) of the EOCBT, ESF and ENC (the sum of the two) regions (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See our previous report12 for a detailed explanation.BMO, ASCO, SFO and Neural Canal Minimum Cross-Sectional Area (NCMCA) Size and Shape Measurements (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Bruch’s membrane opening (BMO), (B) the anterior scleral canal opening (ASCO), (C) the scleral flange opening (SFO) (see Methods) and (D) Neural Canal Minimum Cross-Sectional area (NCMCA) which is an estimate of the smallest dimension of the pre-scleral neural canal through which the retinal ganglion cell axons pass (see Methods and Supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NCMCA (Figure 6 and Supplemental Figure 2)7 estimates the smallest opening that the RGC axons pass through as they move through the pre-scleral neural canal.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The size and ovality index of NCMCA was computed within the projection plane, using the methods described for BMO, the ASCO and the SFO, above.BMO/ASCO Offset Magnitude. (Figure 7 - left).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Subsequently, a best-fit ellipse was fitted to calculate the centroids of both the BMO and ASCO.70,71 The magnitude of BMO/ASCO offset was established by projecting the vector connecting the ASCO and BMO centroids to the BMO reference plane (the BMO/ASCO centroid vector), and transposing it from the projected ASCO centroid to the BMO centroid.BMO/SFO Offset Magnitude (Figure 7 - right).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Global and FoBMO 30° BMO-MRW and pNC-RNFLT data were generated as previously described.12,64 pNC-CT measurements in FoBMO 30⁰ sectors were generated from the 24 radial B-scans, as previously described8,11,12,69 (Supplemental Figure 3). pNC-CT data at the 100, 300, 500 and 700 μm measurement points were represented in microns and as their age-corrected, normative range percentile for each FoBMO sector of each study eye.Subdivision of Study eyes into Hi-ESF and Non-Hi-ESF subgroups.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ENC region sectoral magnitude is greatest and pNC-RNFLT and pNC-CT are thinnest in the inferior-temporal sectors of both the Hi-Myo and Non-Hi-Myo-Healthy eyes (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 4 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the inferior temporal thinning shown in the pNC-CT 300 data included above.The longer sectoral length of the ENC regions and the thinner sectoral thickness of pNC-RNFLT and pNC-CT in the Hi-Myo versus the Non-Hi-Myo-Healthy eyes are also most pronounced within the inferior-temporal sectors.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT at the 300 μm measurement point (pNC-CT 300) data shown in Figure 8.Differences between the Hi-Myo Hi-ESF versus the Non-Hi-Myo-Healthy Hi-ESF eyes (Tables 1–3).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Among the Hi-Myo-GL eyes, while visual field loss was greater in the Hi-ESF compared to the Non-Hi-ESF eyes, this difference did not achieve significance.ENC region sectoral magnitude as well as pNC-RNFLT and pNC-CT are decreased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel), see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 5 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the pNC-CT 300 data included above.Against expectation, while in both groups the inferior temporal sectors demonstrate the highest ENC regional magnitudes and the thinnest pNC-RNFLT and pNC-CT, the sectoral magnitudes of each ENC region and sub-region were decreased rather than increased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (see Discussion).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT-300 data shown in Figure 9.Ocular and Demographic Factors associated with the ENC, EOCBT and ESF regions of the Hi-Myo eyes (Table 7).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "To further clarify these findings, we performed additional univariable and multivariable association studies in “All Study” eyes (Supplemental Table 4, n=484 eyes spanning the full spectrum of axial length and spherical equivalent) and “All Hi-ESF eyes (Supplemental Figure 5, n=160 eyes also spanning the full spectrum of both parameters).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, as would be expected morphologically, (Figure 10), BMO/ASCO offset magnitude consistently predicted the magnitude of the ENC region (except for the “All Study Eye” analysis) and EOCBT region.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "See Table 7 and Supplemental Tables 4 and 5 for the expanded Univariable and Multivariable association data that are summarized herein).Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(Left Panel) The existing exposed neural canal (ENC) region from the 48 year old Hi-Myo-GL-29 example eye from Figure 4 is used to create a “Proposed Longitudinal Change” scenario (Left Middle Panels - top-to-bottom) in which CBT “externalization” and “insertion migration” away from the post-embryonic ASCO creates an ESF region and a geometrically identifiable SFO that is separate from the ASCO.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In this report we have simplified the term to SFO for clarity and now propose that in any cross-sectional OCT images of post-embryonic eyes, (i.e., at any post-embryonic point in life at which the eye is imaged), at radial ONH locations where an SFO point can be identified separate from an ASCO point, the SFO point is the “original” (i.e., “post-embryonic development” or “pre-myopic neural canal remodeling”) entrance to the scleral flange portion of the neural canal.12 (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Likewise, the SFO as an opening, represents the “entrance” to the scleral flange portion of the neural canal at the end of neural canal embryonic development, (though its size, shape and planarity may also have been altered by postembryonic remodeling).12 In this same construct, the ASCO, as detected in the same images, represents the “entrance” to the scleral flange portion of the neural canal after whatever post-embryonic remodeling of the CBT (Figure 10)13 has occurred.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 10, (modified from our previous report),12 uses the Hi-Myo-GL-29 eye from Figure 4 to create a “Proposed Longitudinal Change” scenario in which CBT “externalization” and “insertion migration” away from the “embryonic” entrance to the scleral flange portion of the neural canal creates an ESF region as well as an ASCO point that is separate from a geometrically identifiable SFO point.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 10 also includes a second, “Alternative Longitudinal Change” scenario, in which the CBT become externalized and then elongate progressively without losing their insertion into the post-embryonic ASCO point creating an ENC region that consists entirely of EOCBT.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 11 illustrates how increased peri-neural canal scleral bowing (pNC-SB) and increased neural canal scleral flange bowing (neither of which having been reported in this study) in the Hi-Myo-GL eyes may have increased the “axial” orientation of the scleral flange and in so doing reduced the “transverse extent” of the exposed neural canal (ENC) regions in the Hi-Myo-GL eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "We have previously reported that pNC-SB is greater in the Halifax subset of the Hi-Myo-GL eyes (see methods) compared to the Halifax Hi-Myo-Healthy eyes of this study.11 In a manuscript in preparation, we will measure both neural canal scleral flange bowing (Supplemental Figure 6)11 and “running length” (rather than) “projected length” measures of each ENC region in an expanded group of Hi-Myo-GL versus Hi-Myo-Healthy eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Other Acknowledgments\nAnuwat Jiravarnsirikul and Hongli Yang contributed equally to this work.Abbreviations/Acronyms:\n\nASCO\nanterior sclera canal opening\nBM\nBruch’s Membrane\nBMO\nBruch’s membrane opening\nCBT\nChoroidal Border Tissues – previously referred to by their histologic name (“Border tissues of Elschnig”)\nCCT\ncentral corneal thickness\nCDM\nclinical disc margin\nCSF\nCerebrospinal Fluid\nDIGS\nDiagnostic Innovations in Glaucoma Study\nENC\nexposed Neural Canal\nEOCBT\nExternally Oblique CBT\nESF\nExposed Scleral Flange\nFDA\nFood and Drug Administration\nFoBMO\nFoveal-BMO\nGHT\nGlaucoma Hemifield Test\nHi-ESF\nStudy Eyes in which the ESF region is ≥ 100 μms in at least one sector\nHi-Myo\nHighly myopic eyes\nHi-Myo-Healthy\nHighly myopic healthy eyes\nHi-Myo-GL\nHighly myopic eyes with glaucoma\nIOCBT\nInternally Oblique Choroidal Border Tissues\nIOP\nIntraocular pressure\nMD\nMean Deviation\nMRW\nMinimum Rim Width\nNC\nNeural Canal\nNCMCA\nNeural Canal Minimum Cross-Sectional Area\nNCSFB\nneural canal scleral flange bowing\nNon-Hi-ESF\nStudy eyes in which the ESF region is < 100 μms in all sectors\nNon-Hi-Myo-Healthy\nNon-highly myopic healthy eyes\nPSCO\nPosterior Scleral Canal Opening (Not segmented in this study)\nOCT\noptical coherence tomography\nONH\noptic nerve head\npNC\nperineural canal\npNC-CT\nperineural canal choroidal thickness\npNC-SB\nperineural canal scleral bowing\nRNFL\nretinal nerve fiber layer\nRNFLT\nRNFL thickness\nRPE\nRetinal Pigment Epithelium\nSector\nONH FoBMO 30° (clock-hour) sectors (see Figure 2, Panel (A))\nSFO\nScleral Flange Opening\nSD\nstandard deviation\nSE\nspherical equivalent\nUCSD\nUniversity of California, San Diego\nFootnotes\nPublisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In their absence, the field has only recently begun to build an OCT-based conceptual framework for parameterizing longitudinal “myopic” ONH remodeling.13–16\nIn recent publications,11,12 we have introduced OCT-defined, ONH neural canal and peri-neural canal (pNC) tissue terminology (Figure 1) to identify and distinguish OCT ONH terminology, (which we argue should be based on OCT-detected anatomic landmarks) from the clinical terms “optic disc” and “peripapillary” because these terms, being based on clinical photographic and clinical biomicroscopic assignment of the clinical disc margin, have no consistent OCT-detectable anatomic foundation in the human eye.17,18 Having no consistent anatomic foundation, the clinical disc margin is inconsistently assigned by clinicians18–20 (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Because the clinical disc margin is commonly used in the definitions of “optic disc tilt” and “torsion” as well as the clinical “gamma” and “delta” zones, its use has also contributed to the lack of anatomically consistent OCT definitions for these terms.3–6,21,22\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) The clinical “optic disc” and “peripapillary” regions are defined relative to the clinical disc margin (see Supplemental Figure 1). (B) We propose that OCT examination of the ONH tissues should be organized relative to the OCT-detected Bruch’s membrane opening (BMO) and neural canal. (C) OCT-radial B-scan from the location depicted by the green line in Panel B. (D) We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axon bundles achieve the retrolaminar orbital optic nerve.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We propose these terms so as to distinguish OCT ONH anatomic terminology from the clinical terms optic disc, papilla, and peri-papillary which have no consistent histologic or OCT-detectable anatomic foundation. (see Supplemental Figure 1)We have previously defined23,24 the ONH anatomically and morphologically (Figures 1 and 2 and Supplemental Figure 1) to include the tissues within the neural canal and those immediately adjacent to it.11,12,23 The ONH tissues thus include not just the retinal ganglion cell (RGC) axons, their associated glia and vasculature and the lamina cribrosa (within the neural canal), but also the scleral flange23–26, the pNC-sclera, choroid and retina, the immediate retrolaminar orbital optic nerve, the dural and pial sheath insertions and the medial portion of the inferior oblique muscle insertion (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For this study the scleral flange opening (SFO) was manually segmented either “geometrically” when identifiable (Panels B2 and C2, see Methods) or, when not geometrically identifiable, estimated visually by projecting the anterior laminar surface through the neural canal wall (Panel A2, see methods). (A3 – C3) Existing BMO and ASCO segmentations in combination with the segmented SFO points were used to define the externally oblique CBT (EOCBT) and Exposed Scleral Flange (ESF) which were parameterized within BMO reference plane as shown in Figure 5.We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axons achieve the orbital optic nerve (Figures 1 and 2 and Supplemental Figure 1).7,10,12,23,27 The pre-scleral neural canal extends from Bruch’s membrane opening, (BMO), through the anterior scleral canal opening, (ASCO) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It consists of the choroidal border tissues (CBT) which are known histologically as the border tissues of Elschnig.27–29 The scleral portion of the neural canal extends from the ASCO through the scleral flange opening (SFO), (when present - see Methods and Figures 1–4), ending at the posterior scleral canal opening (PSCO) which can be identified histologically23,30 but is, at present, only inconsistently visualized by OCT (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "All eyes are shown in right eye orientation.In previous 3D-histomorphometric monkey studies,23,24 we defined the scleral flange to be the portion of the pNC-sclera that was “internal” to the PSCO (Figure 2.) In separate histologic studies in post-mortem human eyes,25,26 Jonas defined the scleral flange to be the portion of the pNC-sclera that was “central “or “internal” to the dural sheath insertion.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Second, scleral flange morphology is influenced by the insertion of the dural sheath into the pNC sclera which adds substantial thickness to the posterior sclera peripheral to the flange.25,26\nIn our recent study,12 we manually segmented BMO, the ASCO and the OCT-determined scleral flange opening (SFO), (when present), in 362 non-highly myopic healthy eyes, so as to report the prevalence, magnitude and Foveal-BMO (FoBMO) location of a new, OCT-defined, ONH region - the “exposed neural canal” (ENC) region (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Pre-scleral and scleral flange neural canal anatomy projected onto the fundus photo of study eye Hi-Myo-GL-29, (also shown in Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figures 1–4 provide illustrations and explanations of the anatomic terms associated with the OCT neural canal and scleral flange.11,12\nFigure 4 illustrates OCT examples of ENC regions and sub-regions within representative Non-Hi-Myo-Healthy and Hi-Myo eyes of this study.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "7,8,68,69\nIn eyes with an ESF region, the SFO,12 was anatomically defined to be the transition between the anterior and internal surfaces of the scleral flange (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was manually segmented “geometrically” (Figure 2, Panels B2 and C2) when the transition from the “anterior” to the “internal” scleral flange surfaces (Figure 2, Panel C2), was acute enough to be visually identified.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes where the transition was not visually discernible (see Discussion), the operator “estimated” the SFO by visually projecting the anterior laminar surface through the neural canal wall (Figure 2, Panel A2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In all instances, and for all segmentations, the operator was able to inspect adjacent B-scans on either side of the B-scan in question to inform their final SFO segmentation choice within a given B-scan.Sectoral ENC, EOCBT and ESF Measurements (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See Figure 3 for the 30° sectoral acronym names shown in Panel E.For each eye, segmented BMO, ASCO and SFO points along with BMO centroid (the centroid of the segmented BMO points) were projected to the BMO reference plane (Figure 5A – 5D) for re-sampled measurement within 30° sectors (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Within each sector, four equally-spaced re-sampling lines were used to measure the radial extent (magnitude) of the EOCBT, ESF and ENC (the sum of the two) regions (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See our previous report12 for a detailed explanation.BMO, ASCO, SFO and Neural Canal Minimum Cross-Sectional Area (NCMCA) Size and Shape Measurements (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Bruch’s membrane opening (BMO), (B) the anterior scleral canal opening (ASCO), (C) the scleral flange opening (SFO) (see Methods) and (D) Neural Canal Minimum Cross-Sectional area (NCMCA) which is an estimate of the smallest dimension of the pre-scleral neural canal through which the retinal ganglion cell axons pass (see Methods and Supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NCMCA (Figure 6 and Supplemental Figure 2)7 estimates the smallest opening that the RGC axons pass through as they move through the pre-scleral neural canal.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The size and ovality index of NCMCA was computed within the projection plane, using the methods described for BMO, the ASCO and the SFO, above.BMO/ASCO Offset Magnitude. (Figure 7 - left).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Subsequently, a best-fit ellipse was fitted to calculate the centroids of both the BMO and ASCO.70,71 The magnitude of BMO/ASCO offset was established by projecting the vector connecting the ASCO and BMO centroids to the BMO reference plane (the BMO/ASCO centroid vector), and transposing it from the projected ASCO centroid to the BMO centroid.BMO/SFO Offset Magnitude (Figure 7 - right).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Global and FoBMO 30° BMO-MRW and pNC-RNFLT data were generated as previously described.12,64 pNC-CT measurements in FoBMO 30⁰ sectors were generated from the 24 radial B-scans, as previously described8,11,12,69 (Supplemental Figure 3). pNC-CT data at the 100, 300, 500 and 700 μm measurement points were represented in microns and as their age-corrected, normative range percentile for each FoBMO sector of each study eye.Subdivision of Study eyes into Hi-ESF and Non-Hi-ESF subgroups.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ENC region sectoral magnitude is greatest and pNC-RNFLT and pNC-CT are thinnest in the inferior-temporal sectors of both the Hi-Myo and Non-Hi-Myo-Healthy eyes (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 4 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the inferior temporal thinning shown in the pNC-CT 300 data included above.The longer sectoral length of the ENC regions and the thinner sectoral thickness of pNC-RNFLT and pNC-CT in the Hi-Myo versus the Non-Hi-Myo-Healthy eyes are also most pronounced within the inferior-temporal sectors.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT at the 300 μm measurement point (pNC-CT 300) data shown in Figure 8.Differences between the Hi-Myo Hi-ESF versus the Non-Hi-Myo-Healthy Hi-ESF eyes (Tables 1–3).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Among the Hi-Myo-GL eyes, while visual field loss was greater in the Hi-ESF compared to the Non-Hi-ESF eyes, this difference did not achieve significance.ENC region sectoral magnitude as well as pNC-RNFLT and pNC-CT are decreased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel), see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 5 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the pNC-CT 300 data included above.Against expectation, while in both groups the inferior temporal sectors demonstrate the highest ENC regional magnitudes and the thinnest pNC-RNFLT and pNC-CT, the sectoral magnitudes of each ENC region and sub-region were decreased rather than increased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (see Discussion).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT-300 data shown in Figure 9.Ocular and Demographic Factors associated with the ENC, EOCBT and ESF regions of the Hi-Myo eyes (Table 7).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "To further clarify these findings, we performed additional univariable and multivariable association studies in “All Study” eyes (Supplemental Table 4, n=484 eyes spanning the full spectrum of axial length and spherical equivalent) and “All Hi-ESF eyes (Supplemental Figure 5, n=160 eyes also spanning the full spectrum of both parameters).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, as would be expected morphologically, (Figure 10), BMO/ASCO offset magnitude consistently predicted the magnitude of the ENC region (except for the “All Study Eye” analysis) and EOCBT region.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "See Table 7 and Supplemental Tables 4 and 5 for the expanded Univariable and Multivariable association data that are summarized herein).Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(Left Panel) The existing exposed neural canal (ENC) region from the 48 year old Hi-Myo-GL-29 example eye from Figure 4 is used to create a “Proposed Longitudinal Change” scenario (Left Middle Panels - top-to-bottom) in which CBT “externalization” and “insertion migration” away from the post-embryonic ASCO creates an ESF region and a geometrically identifiable SFO that is separate from the ASCO.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In this report we have simplified the term to SFO for clarity and now propose that in any cross-sectional OCT images of post-embryonic eyes, (i.e., at any post-embryonic point in life at which the eye is imaged), at radial ONH locations where an SFO point can be identified separate from an ASCO point, the SFO point is the “original” (i.e., “post-embryonic development” or “pre-myopic neural canal remodeling”) entrance to the scleral flange portion of the neural canal.12 (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Likewise, the SFO as an opening, represents the “entrance” to the scleral flange portion of the neural canal at the end of neural canal embryonic development, (though its size, shape and planarity may also have been altered by postembryonic remodeling).12 In this same construct, the ASCO, as detected in the same images, represents the “entrance” to the scleral flange portion of the neural canal after whatever post-embryonic remodeling of the CBT (Figure 10)13 has occurred.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 10, (modified from our previous report),12 uses the Hi-Myo-GL-29 eye from Figure 4 to create a “Proposed Longitudinal Change” scenario in which CBT “externalization” and “insertion migration” away from the “embryonic” entrance to the scleral flange portion of the neural canal creates an ESF region as well as an ASCO point that is separate from a geometrically identifiable SFO point.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 10 also includes a second, “Alternative Longitudinal Change” scenario, in which the CBT become externalized and then elongate progressively without losing their insertion into the post-embryonic ASCO point creating an ENC region that consists entirely of EOCBT.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 11 illustrates how increased peri-neural canal scleral bowing (pNC-SB) and increased neural canal scleral flange bowing (neither of which having been reported in this study) in the Hi-Myo-GL eyes may have increased the “axial” orientation of the scleral flange and in so doing reduced the “transverse extent” of the exposed neural canal (ENC) regions in the Hi-Myo-GL eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "We have previously reported that pNC-SB is greater in the Halifax subset of the Hi-Myo-GL eyes (see methods) compared to the Halifax Hi-Myo-Healthy eyes of this study.11 In a manuscript in preparation, we will measure both neural canal scleral flange bowing (Supplemental Figure 6)11 and “running length” (rather than) “projected length” measures of each ENC region in an expanded group of Hi-Myo-GL versus Hi-Myo-Healthy eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Other Acknowledgments\nAnuwat Jiravarnsirikul and Hongli Yang contributed equally to this work.Abbreviations/Acronyms:\n\nASCO\nanterior sclera canal opening\nBM\nBruch’s Membrane\nBMO\nBruch’s membrane opening\nCBT\nChoroidal Border Tissues – previously referred to by their histologic name (“Border tissues of Elschnig”)\nCCT\ncentral corneal thickness\nCDM\nclinical disc margin\nCSF\nCerebrospinal Fluid\nDIGS\nDiagnostic Innovations in Glaucoma Study\nENC\nexposed Neural Canal\nEOCBT\nExternally Oblique CBT\nESF\nExposed Scleral Flange\nFDA\nFood and Drug Administration\nFoBMO\nFoveal-BMO\nGHT\nGlaucoma Hemifield Test\nHi-ESF\nStudy Eyes in which the ESF region is ≥ 100 μms in at least one sector\nHi-Myo\nHighly myopic eyes\nHi-Myo-Healthy\nHighly myopic healthy eyes\nHi-Myo-GL\nHighly myopic eyes with glaucoma\nIOCBT\nInternally Oblique Choroidal Border Tissues\nIOP\nIntraocular pressure\nMD\nMean Deviation\nMRW\nMinimum Rim Width\nNC\nNeural Canal\nNCMCA\nNeural Canal Minimum Cross-Sectional Area\nNCSFB\nneural canal scleral flange bowing\nNon-Hi-ESF\nStudy eyes in which the ESF region is < 100 μms in all sectors\nNon-Hi-Myo-Healthy\nNon-highly myopic healthy eyes\nPSCO\nPosterior Scleral Canal Opening (Not segmented in this study)\nOCT\noptical coherence tomography\nONH\noptic nerve head\npNC\nperineural canal\npNC-CT\nperineural canal choroidal thickness\npNC-SB\nperineural canal scleral bowing\nRNFL\nretinal nerve fiber layer\nRNFLT\nRNFL thickness\nRPE\nRetinal Pigment Epithelium\nSector\nONH FoBMO 30° (clock-hour) sectors (see Figure 2, Panel (A))\nSFO\nScleral Flange Opening\nSD\nstandard deviation\nSE\nspherical equivalent\nUCSD\nUniversity of California, San Diego\nFootnotes\nPublisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In their absence, the field has only recently begun to build an OCT-based conceptual framework for parameterizing longitudinal “myopic” ONH remodeling.13–16\nIn recent publications,11,12 we have introduced OCT-defined, ONH neural canal and peri-neural canal (pNC) tissue terminology (Figure 1) to identify and distinguish OCT ONH terminology, (which we argue should be based on OCT-detected anatomic landmarks) from the clinical terms “optic disc” and “peripapillary” because these terms, being based on clinical photographic and clinical biomicroscopic assignment of the clinical disc margin, have no consistent OCT-detectable anatomic foundation in the human eye.17,18 Having no consistent anatomic foundation, the clinical disc margin is inconsistently assigned by clinicians18–20 (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Because the clinical disc margin is commonly used in the definitions of “optic disc tilt” and “torsion” as well as the clinical “gamma” and “delta” zones, its use has also contributed to the lack of anatomically consistent OCT definitions for these terms.3–6,21,22\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) The clinical “optic disc” and “peripapillary” regions are defined relative to the clinical disc margin (see Supplemental Figure 1). (B) We propose that OCT examination of the ONH tissues should be organized relative to the OCT-detected Bruch’s membrane opening (BMO) and neural canal. (C) OCT-radial B-scan from the location depicted by the green line in Panel B. (D) We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axon bundles achieve the retrolaminar orbital optic nerve.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We propose these terms so as to distinguish OCT ONH anatomic terminology from the clinical terms optic disc, papilla, and peri-papillary which have no consistent histologic or OCT-detectable anatomic foundation. (see Supplemental Figure 1)We have previously defined23,24 the ONH anatomically and morphologically (Figures 1 and 2 and Supplemental Figure 1) to include the tissues within the neural canal and those immediately adjacent to it.11,12,23 The ONH tissues thus include not just the retinal ganglion cell (RGC) axons, their associated glia and vasculature and the lamina cribrosa (within the neural canal), but also the scleral flange23–26, the pNC-sclera, choroid and retina, the immediate retrolaminar orbital optic nerve, the dural and pial sheath insertions and the medial portion of the inferior oblique muscle insertion (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For this study the scleral flange opening (SFO) was manually segmented either “geometrically” when identifiable (Panels B2 and C2, see Methods) or, when not geometrically identifiable, estimated visually by projecting the anterior laminar surface through the neural canal wall (Panel A2, see methods). (A3 – C3) Existing BMO and ASCO segmentations in combination with the segmented SFO points were used to define the externally oblique CBT (EOCBT) and Exposed Scleral Flange (ESF) which were parameterized within BMO reference plane as shown in Figure 5.We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axons achieve the orbital optic nerve (Figures 1 and 2 and Supplemental Figure 1).7,10,12,23,27 The pre-scleral neural canal extends from Bruch’s membrane opening, (BMO), through the anterior scleral canal opening, (ASCO) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It consists of the choroidal border tissues (CBT) which are known histologically as the border tissues of Elschnig.27–29 The scleral portion of the neural canal extends from the ASCO through the scleral flange opening (SFO), (when present - see Methods and Figures 1–4), ending at the posterior scleral canal opening (PSCO) which can be identified histologically23,30 but is, at present, only inconsistently visualized by OCT (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "All eyes are shown in right eye orientation.In previous 3D-histomorphometric monkey studies,23,24 we defined the scleral flange to be the portion of the pNC-sclera that was “internal” to the PSCO (Figure 2.) In separate histologic studies in post-mortem human eyes,25,26 Jonas defined the scleral flange to be the portion of the pNC-sclera that was “central “or “internal” to the dural sheath insertion.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Second, scleral flange morphology is influenced by the insertion of the dural sheath into the pNC sclera which adds substantial thickness to the posterior sclera peripheral to the flange.25,26\nIn our recent study,12 we manually segmented BMO, the ASCO and the OCT-determined scleral flange opening (SFO), (when present), in 362 non-highly myopic healthy eyes, so as to report the prevalence, magnitude and Foveal-BMO (FoBMO) location of a new, OCT-defined, ONH region - the “exposed neural canal” (ENC) region (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Pre-scleral and scleral flange neural canal anatomy projected onto the fundus photo of study eye Hi-Myo-GL-29, (also shown in Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figures 1–4 provide illustrations and explanations of the anatomic terms associated with the OCT neural canal and scleral flange.11,12\nFigure 4 illustrates OCT examples of ENC regions and sub-regions within representative Non-Hi-Myo-Healthy and Hi-Myo eyes of this study.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "7,8,68,69\nIn eyes with an ESF region, the SFO,12 was anatomically defined to be the transition between the anterior and internal surfaces of the scleral flange (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was manually segmented “geometrically” (Figure 2, Panels B2 and C2) when the transition from the “anterior” to the “internal” scleral flange surfaces (Figure 2, Panel C2), was acute enough to be visually identified.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes where the transition was not visually discernible (see Discussion), the operator “estimated” the SFO by visually projecting the anterior laminar surface through the neural canal wall (Figure 2, Panel A2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In all instances, and for all segmentations, the operator was able to inspect adjacent B-scans on either side of the B-scan in question to inform their final SFO segmentation choice within a given B-scan.Sectoral ENC, EOCBT and ESF Measurements (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See Figure 3 for the 30° sectoral acronym names shown in Panel E.For each eye, segmented BMO, ASCO and SFO points along with BMO centroid (the centroid of the segmented BMO points) were projected to the BMO reference plane (Figure 5A – 5D) for re-sampled measurement within 30° sectors (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Within each sector, four equally-spaced re-sampling lines were used to measure the radial extent (magnitude) of the EOCBT, ESF and ENC (the sum of the two) regions (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See our previous report12 for a detailed explanation.BMO, ASCO, SFO and Neural Canal Minimum Cross-Sectional Area (NCMCA) Size and Shape Measurements (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Bruch’s membrane opening (BMO), (B) the anterior scleral canal opening (ASCO), (C) the scleral flange opening (SFO) (see Methods) and (D) Neural Canal Minimum Cross-Sectional area (NCMCA) which is an estimate of the smallest dimension of the pre-scleral neural canal through which the retinal ganglion cell axons pass (see Methods and Supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NCMCA (Figure 6 and Supplemental Figure 2)7 estimates the smallest opening that the RGC axons pass through as they move through the pre-scleral neural canal.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The size and ovality index of NCMCA was computed within the projection plane, using the methods described for BMO, the ASCO and the SFO, above.BMO/ASCO Offset Magnitude. (Figure 7 - left).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Subsequently, a best-fit ellipse was fitted to calculate the centroids of both the BMO and ASCO.70,71 The magnitude of BMO/ASCO offset was established by projecting the vector connecting the ASCO and BMO centroids to the BMO reference plane (the BMO/ASCO centroid vector), and transposing it from the projected ASCO centroid to the BMO centroid.BMO/SFO Offset Magnitude (Figure 7 - right).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Global and FoBMO 30° BMO-MRW and pNC-RNFLT data were generated as previously described.12,64 pNC-CT measurements in FoBMO 30⁰ sectors were generated from the 24 radial B-scans, as previously described8,11,12,69 (Supplemental Figure 3). pNC-CT data at the 100, 300, 500 and 700 μm measurement points were represented in microns and as their age-corrected, normative range percentile for each FoBMO sector of each study eye.Subdivision of Study eyes into Hi-ESF and Non-Hi-ESF subgroups.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ENC region sectoral magnitude is greatest and pNC-RNFLT and pNC-CT are thinnest in the inferior-temporal sectors of both the Hi-Myo and Non-Hi-Myo-Healthy eyes (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 4 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the inferior temporal thinning shown in the pNC-CT 300 data included above.The longer sectoral length of the ENC regions and the thinner sectoral thickness of pNC-RNFLT and pNC-CT in the Hi-Myo versus the Non-Hi-Myo-Healthy eyes are also most pronounced within the inferior-temporal sectors.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT at the 300 μm measurement point (pNC-CT 300) data shown in Figure 8.Differences between the Hi-Myo Hi-ESF versus the Non-Hi-Myo-Healthy Hi-ESF eyes (Tables 1–3).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Among the Hi-Myo-GL eyes, while visual field loss was greater in the Hi-ESF compared to the Non-Hi-ESF eyes, this difference did not achieve significance.ENC region sectoral magnitude as well as pNC-RNFLT and pNC-CT are decreased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel), see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 5 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the pNC-CT 300 data included above.Against expectation, while in both groups the inferior temporal sectors demonstrate the highest ENC regional magnitudes and the thinnest pNC-RNFLT and pNC-CT, the sectoral magnitudes of each ENC region and sub-region were decreased rather than increased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (see Discussion).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT-300 data shown in Figure 9.Ocular and Demographic Factors associated with the ENC, EOCBT and ESF regions of the Hi-Myo eyes (Table 7).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "To further clarify these findings, we performed additional univariable and multivariable association studies in “All Study” eyes (Supplemental Table 4, n=484 eyes spanning the full spectrum of axial length and spherical equivalent) and “All Hi-ESF eyes (Supplemental Figure 5, n=160 eyes also spanning the full spectrum of both parameters).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, as would be expected morphologically, (Figure 10), BMO/ASCO offset magnitude consistently predicted the magnitude of the ENC region (except for the “All Study Eye” analysis) and EOCBT region.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "See Table 7 and Supplemental Tables 4 and 5 for the expanded Univariable and Multivariable association data that are summarized herein).Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(Left Panel) The existing exposed neural canal (ENC) region from the 48 year old Hi-Myo-GL-29 example eye from Figure 4 is used to create a “Proposed Longitudinal Change” scenario (Left Middle Panels - top-to-bottom) in which CBT “externalization” and “insertion migration” away from the post-embryonic ASCO creates an ESF region and a geometrically identifiable SFO that is separate from the ASCO.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In this report we have simplified the term to SFO for clarity and now propose that in any cross-sectional OCT images of post-embryonic eyes, (i.e., at any post-embryonic point in life at which the eye is imaged), at radial ONH locations where an SFO point can be identified separate from an ASCO point, the SFO point is the “original” (i.e., “post-embryonic development” or “pre-myopic neural canal remodeling”) entrance to the scleral flange portion of the neural canal.12 (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Likewise, the SFO as an opening, represents the “entrance” to the scleral flange portion of the neural canal at the end of neural canal embryonic development, (though its size, shape and planarity may also have been altered by postembryonic remodeling).12 In this same construct, the ASCO, as detected in the same images, represents the “entrance” to the scleral flange portion of the neural canal after whatever post-embryonic remodeling of the CBT (Figure 10)13 has occurred.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 10, (modified from our previous report),12 uses the Hi-Myo-GL-29 eye from Figure 4 to create a “Proposed Longitudinal Change” scenario in which CBT “externalization” and “insertion migration” away from the “embryonic” entrance to the scleral flange portion of the neural canal creates an ESF region as well as an ASCO point that is separate from a geometrically identifiable SFO point.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 10 also includes a second, “Alternative Longitudinal Change” scenario, in which the CBT become externalized and then elongate progressively without losing their insertion into the post-embryonic ASCO point creating an ENC region that consists entirely of EOCBT.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 11 illustrates how increased peri-neural canal scleral bowing (pNC-SB) and increased neural canal scleral flange bowing (neither of which having been reported in this study) in the Hi-Myo-GL eyes may have increased the “axial” orientation of the scleral flange and in so doing reduced the “transverse extent” of the exposed neural canal (ENC) regions in the Hi-Myo-GL eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "We have previously reported that pNC-SB is greater in the Halifax subset of the Hi-Myo-GL eyes (see methods) compared to the Halifax Hi-Myo-Healthy eyes of this study.11 In a manuscript in preparation, we will measure both neural canal scleral flange bowing (Supplemental Figure 6)11 and “running length” (rather than) “projected length” measures of each ENC region in an expanded group of Hi-Myo-GL versus Hi-Myo-Healthy eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Other Acknowledgments\nAnuwat Jiravarnsirikul and Hongli Yang contributed equally to this work.Abbreviations/Acronyms:\n\nASCO\nanterior sclera canal opening\nBM\nBruch’s Membrane\nBMO\nBruch’s membrane opening\nCBT\nChoroidal Border Tissues – previously referred to by their histologic name (“Border tissues of Elschnig”)\nCCT\ncentral corneal thickness\nCDM\nclinical disc margin\nCSF\nCerebrospinal Fluid\nDIGS\nDiagnostic Innovations in Glaucoma Study\nENC\nexposed Neural Canal\nEOCBT\nExternally Oblique CBT\nESF\nExposed Scleral Flange\nFDA\nFood and Drug Administration\nFoBMO\nFoveal-BMO\nGHT\nGlaucoma Hemifield Test\nHi-ESF\nStudy Eyes in which the ESF region is ≥ 100 μms in at least one sector\nHi-Myo\nHighly myopic eyes\nHi-Myo-Healthy\nHighly myopic healthy eyes\nHi-Myo-GL\nHighly myopic eyes with glaucoma\nIOCBT\nInternally Oblique Choroidal Border Tissues\nIOP\nIntraocular pressure\nMD\nMean Deviation\nMRW\nMinimum Rim Width\nNC\nNeural Canal\nNCMCA\nNeural Canal Minimum Cross-Sectional Area\nNCSFB\nneural canal scleral flange bowing\nNon-Hi-ESF\nStudy eyes in which the ESF region is < 100 μms in all sectors\nNon-Hi-Myo-Healthy\nNon-highly myopic healthy eyes\nPSCO\nPosterior Scleral Canal Opening (Not segmented in this study)\nOCT\noptical coherence tomography\nONH\noptic nerve head\npNC\nperineural canal\npNC-CT\nperineural canal choroidal thickness\npNC-SB\nperineural canal scleral bowing\nRNFL\nretinal nerve fiber layer\nRNFLT\nRNFL thickness\nRPE\nRetinal Pigment Epithelium\nSector\nONH FoBMO 30° (clock-hour) sectors (see Figure 2, Panel (A))\nSFO\nScleral Flange Opening\nSD\nstandard deviation\nSE\nspherical equivalent\nUCSD\nUniversity of California, San Diego\nFootnotes\nPublisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In their absence, the field has only recently begun to build an OCT-based conceptual framework for parameterizing longitudinal “myopic” ONH remodeling.13–16\nIn recent publications,11,12 we have introduced OCT-defined, ONH neural canal and peri-neural canal (pNC) tissue terminology (Figure 1) to identify and distinguish OCT ONH terminology, (which we argue should be based on OCT-detected anatomic landmarks) from the clinical terms “optic disc” and “peripapillary” because these terms, being based on clinical photographic and clinical biomicroscopic assignment of the clinical disc margin, have no consistent OCT-detectable anatomic foundation in the human eye.17,18 Having no consistent anatomic foundation, the clinical disc margin is inconsistently assigned by clinicians18–20 (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Because the clinical disc margin is commonly used in the definitions of “optic disc tilt” and “torsion” as well as the clinical “gamma” and “delta” zones, its use has also contributed to the lack of anatomically consistent OCT definitions for these terms.3–6,21,22\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) The clinical “optic disc” and “peripapillary” regions are defined relative to the clinical disc margin (see Supplemental Figure 1). (B) We propose that OCT examination of the ONH tissues should be organized relative to the OCT-detected Bruch’s membrane opening (BMO) and neural canal. (C) OCT-radial B-scan from the location depicted by the green line in Panel B. (D) We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axon bundles achieve the retrolaminar orbital optic nerve.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We propose these terms so as to distinguish OCT ONH anatomic terminology from the clinical terms optic disc, papilla, and peri-papillary which have no consistent histologic or OCT-detectable anatomic foundation. (see Supplemental Figure 1)We have previously defined23,24 the ONH anatomically and morphologically (Figures 1 and 2 and Supplemental Figure 1) to include the tissues within the neural canal and those immediately adjacent to it.11,12,23 The ONH tissues thus include not just the retinal ganglion cell (RGC) axons, their associated glia and vasculature and the lamina cribrosa (within the neural canal), but also the scleral flange23–26, the pNC-sclera, choroid and retina, the immediate retrolaminar orbital optic nerve, the dural and pial sheath insertions and the medial portion of the inferior oblique muscle insertion (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For this study the scleral flange opening (SFO) was manually segmented either “geometrically” when identifiable (Panels B2 and C2, see Methods) or, when not geometrically identifiable, estimated visually by projecting the anterior laminar surface through the neural canal wall (Panel A2, see methods). (A3 – C3) Existing BMO and ASCO segmentations in combination with the segmented SFO points were used to define the externally oblique CBT (EOCBT) and Exposed Scleral Flange (ESF) which were parameterized within BMO reference plane as shown in Figure 5.We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axons achieve the orbital optic nerve (Figures 1 and 2 and Supplemental Figure 1).7,10,12,23,27 The pre-scleral neural canal extends from Bruch’s membrane opening, (BMO), through the anterior scleral canal opening, (ASCO) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It consists of the choroidal border tissues (CBT) which are known histologically as the border tissues of Elschnig.27–29 The scleral portion of the neural canal extends from the ASCO through the scleral flange opening (SFO), (when present - see Methods and Figures 1–4), ending at the posterior scleral canal opening (PSCO) which can be identified histologically23,30 but is, at present, only inconsistently visualized by OCT (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "All eyes are shown in right eye orientation.In previous 3D-histomorphometric monkey studies,23,24 we defined the scleral flange to be the portion of the pNC-sclera that was “internal” to the PSCO (Figure 2.) In separate histologic studies in post-mortem human eyes,25,26 Jonas defined the scleral flange to be the portion of the pNC-sclera that was “central “or “internal” to the dural sheath insertion.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Second, scleral flange morphology is influenced by the insertion of the dural sheath into the pNC sclera which adds substantial thickness to the posterior sclera peripheral to the flange.25,26\nIn our recent study,12 we manually segmented BMO, the ASCO and the OCT-determined scleral flange opening (SFO), (when present), in 362 non-highly myopic healthy eyes, so as to report the prevalence, magnitude and Foveal-BMO (FoBMO) location of a new, OCT-defined, ONH region - the “exposed neural canal” (ENC) region (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Pre-scleral and scleral flange neural canal anatomy projected onto the fundus photo of study eye Hi-Myo-GL-29, (also shown in Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figures 1–4 provide illustrations and explanations of the anatomic terms associated with the OCT neural canal and scleral flange.11,12\nFigure 4 illustrates OCT examples of ENC regions and sub-regions within representative Non-Hi-Myo-Healthy and Hi-Myo eyes of this study.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "7,8,68,69\nIn eyes with an ESF region, the SFO,12 was anatomically defined to be the transition between the anterior and internal surfaces of the scleral flange (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was manually segmented “geometrically” (Figure 2, Panels B2 and C2) when the transition from the “anterior” to the “internal” scleral flange surfaces (Figure 2, Panel C2), was acute enough to be visually identified.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes where the transition was not visually discernible (see Discussion), the operator “estimated” the SFO by visually projecting the anterior laminar surface through the neural canal wall (Figure 2, Panel A2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In all instances, and for all segmentations, the operator was able to inspect adjacent B-scans on either side of the B-scan in question to inform their final SFO segmentation choice within a given B-scan.Sectoral ENC, EOCBT and ESF Measurements (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See Figure 3 for the 30° sectoral acronym names shown in Panel E.For each eye, segmented BMO, ASCO and SFO points along with BMO centroid (the centroid of the segmented BMO points) were projected to the BMO reference plane (Figure 5A – 5D) for re-sampled measurement within 30° sectors (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Within each sector, four equally-spaced re-sampling lines were used to measure the radial extent (magnitude) of the EOCBT, ESF and ENC (the sum of the two) regions (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See our previous report12 for a detailed explanation.BMO, ASCO, SFO and Neural Canal Minimum Cross-Sectional Area (NCMCA) Size and Shape Measurements (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Bruch’s membrane opening (BMO), (B) the anterior scleral canal opening (ASCO), (C) the scleral flange opening (SFO) (see Methods) and (D) Neural Canal Minimum Cross-Sectional area (NCMCA) which is an estimate of the smallest dimension of the pre-scleral neural canal through which the retinal ganglion cell axons pass (see Methods and Supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NCMCA (Figure 6 and Supplemental Figure 2)7 estimates the smallest opening that the RGC axons pass through as they move through the pre-scleral neural canal.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The size and ovality index of NCMCA was computed within the projection plane, using the methods described for BMO, the ASCO and the SFO, above.BMO/ASCO Offset Magnitude. (Figure 7 - left).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Subsequently, a best-fit ellipse was fitted to calculate the centroids of both the BMO and ASCO.70,71 The magnitude of BMO/ASCO offset was established by projecting the vector connecting the ASCO and BMO centroids to the BMO reference plane (the BMO/ASCO centroid vector), and transposing it from the projected ASCO centroid to the BMO centroid.BMO/SFO Offset Magnitude (Figure 7 - right).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Global and FoBMO 30° BMO-MRW and pNC-RNFLT data were generated as previously described.12,64 pNC-CT measurements in FoBMO 30⁰ sectors were generated from the 24 radial B-scans, as previously described8,11,12,69 (Supplemental Figure 3). pNC-CT data at the 100, 300, 500 and 700 μm measurement points were represented in microns and as their age-corrected, normative range percentile for each FoBMO sector of each study eye.Subdivision of Study eyes into Hi-ESF and Non-Hi-ESF subgroups.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ENC region sectoral magnitude is greatest and pNC-RNFLT and pNC-CT are thinnest in the inferior-temporal sectors of both the Hi-Myo and Non-Hi-Myo-Healthy eyes (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 4 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the inferior temporal thinning shown in the pNC-CT 300 data included above.The longer sectoral length of the ENC regions and the thinner sectoral thickness of pNC-RNFLT and pNC-CT in the Hi-Myo versus the Non-Hi-Myo-Healthy eyes are also most pronounced within the inferior-temporal sectors.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT at the 300 μm measurement point (pNC-CT 300) data shown in Figure 8.Differences between the Hi-Myo Hi-ESF versus the Non-Hi-Myo-Healthy Hi-ESF eyes (Tables 1–3).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Among the Hi-Myo-GL eyes, while visual field loss was greater in the Hi-ESF compared to the Non-Hi-ESF eyes, this difference did not achieve significance.ENC region sectoral magnitude as well as pNC-RNFLT and pNC-CT are decreased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel), see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 5 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the pNC-CT 300 data included above.Against expectation, while in both groups the inferior temporal sectors demonstrate the highest ENC regional magnitudes and the thinnest pNC-RNFLT and pNC-CT, the sectoral magnitudes of each ENC region and sub-region were decreased rather than increased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (see Discussion).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT-300 data shown in Figure 9.Ocular and Demographic Factors associated with the ENC, EOCBT and ESF regions of the Hi-Myo eyes (Table 7).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "To further clarify these findings, we performed additional univariable and multivariable association studies in “All Study” eyes (Supplemental Table 4, n=484 eyes spanning the full spectrum of axial length and spherical equivalent) and “All Hi-ESF eyes (Supplemental Figure 5, n=160 eyes also spanning the full spectrum of both parameters).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, as would be expected morphologically, (Figure 10), BMO/ASCO offset magnitude consistently predicted the magnitude of the ENC region (except for the “All Study Eye” analysis) and EOCBT region.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "See Table 7 and Supplemental Tables 4 and 5 for the expanded Univariable and Multivariable association data that are summarized herein).Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(Left Panel) The existing exposed neural canal (ENC) region from the 48 year old Hi-Myo-GL-29 example eye from Figure 4 is used to create a “Proposed Longitudinal Change” scenario (Left Middle Panels - top-to-bottom) in which CBT “externalization” and “insertion migration” away from the post-embryonic ASCO creates an ESF region and a geometrically identifiable SFO that is separate from the ASCO.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In this report we have simplified the term to SFO for clarity and now propose that in any cross-sectional OCT images of post-embryonic eyes, (i.e., at any post-embryonic point in life at which the eye is imaged), at radial ONH locations where an SFO point can be identified separate from an ASCO point, the SFO point is the “original” (i.e., “post-embryonic development” or “pre-myopic neural canal remodeling”) entrance to the scleral flange portion of the neural canal.12 (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Likewise, the SFO as an opening, represents the “entrance” to the scleral flange portion of the neural canal at the end of neural canal embryonic development, (though its size, shape and planarity may also have been altered by postembryonic remodeling).12 In this same construct, the ASCO, as detected in the same images, represents the “entrance” to the scleral flange portion of the neural canal after whatever post-embryonic remodeling of the CBT (Figure 10)13 has occurred.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 10, (modified from our previous report),12 uses the Hi-Myo-GL-29 eye from Figure 4 to create a “Proposed Longitudinal Change” scenario in which CBT “externalization” and “insertion migration” away from the “embryonic” entrance to the scleral flange portion of the neural canal creates an ESF region as well as an ASCO point that is separate from a geometrically identifiable SFO point.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 10 also includes a second, “Alternative Longitudinal Change” scenario, in which the CBT become externalized and then elongate progressively without losing their insertion into the post-embryonic ASCO point creating an ENC region that consists entirely of EOCBT.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 11 illustrates how increased peri-neural canal scleral bowing (pNC-SB) and increased neural canal scleral flange bowing (neither of which having been reported in this study) in the Hi-Myo-GL eyes may have increased the “axial” orientation of the scleral flange and in so doing reduced the “transverse extent” of the exposed neural canal (ENC) regions in the Hi-Myo-GL eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "We have previously reported that pNC-SB is greater in the Halifax subset of the Hi-Myo-GL eyes (see methods) compared to the Halifax Hi-Myo-Healthy eyes of this study.11 In a manuscript in preparation, we will measure both neural canal scleral flange bowing (Supplemental Figure 6)11 and “running length” (rather than) “projected length” measures of each ENC region in an expanded group of Hi-Myo-GL versus Hi-Myo-Healthy eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Other Acknowledgments\nAnuwat Jiravarnsirikul and Hongli Yang contributed equally to this work.Abbreviations/Acronyms:\n\nASCO\nanterior sclera canal opening\nBM\nBruch’s Membrane\nBMO\nBruch’s membrane opening\nCBT\nChoroidal Border Tissues – previously referred to by their histologic name (“Border tissues of Elschnig”)\nCCT\ncentral corneal thickness\nCDM\nclinical disc margin\nCSF\nCerebrospinal Fluid\nDIGS\nDiagnostic Innovations in Glaucoma Study\nENC\nexposed Neural Canal\nEOCBT\nExternally Oblique CBT\nESF\nExposed Scleral Flange\nFDA\nFood and Drug Administration\nFoBMO\nFoveal-BMO\nGHT\nGlaucoma Hemifield Test\nHi-ESF\nStudy Eyes in which the ESF region is ≥ 100 μms in at least one sector\nHi-Myo\nHighly myopic eyes\nHi-Myo-Healthy\nHighly myopic healthy eyes\nHi-Myo-GL\nHighly myopic eyes with glaucoma\nIOCBT\nInternally Oblique Choroidal Border Tissues\nIOP\nIntraocular pressure\nMD\nMean Deviation\nMRW\nMinimum Rim Width\nNC\nNeural Canal\nNCMCA\nNeural Canal Minimum Cross-Sectional Area\nNCSFB\nneural canal scleral flange bowing\nNon-Hi-ESF\nStudy eyes in which the ESF region is < 100 μms in all sectors\nNon-Hi-Myo-Healthy\nNon-highly myopic healthy eyes\nPSCO\nPosterior Scleral Canal Opening (Not segmented in this study)\nOCT\noptical coherence tomography\nONH\noptic nerve head\npNC\nperineural canal\npNC-CT\nperineural canal choroidal thickness\npNC-SB\nperineural canal scleral bowing\nRNFL\nretinal nerve fiber layer\nRNFLT\nRNFL thickness\nRPE\nRetinal Pigment Epithelium\nSector\nONH FoBMO 30° (clock-hour) sectors (see Figure 2, Panel (A))\nSFO\nScleral Flange Opening\nSD\nstandard deviation\nSE\nspherical equivalent\nUCSD\nUniversity of California, San Diego\nFootnotes\nPublisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In their absence, the field has only recently begun to build an OCT-based conceptual framework for parameterizing longitudinal “myopic” ONH remodeling.13–16\nIn recent publications,11,12 we have introduced OCT-defined, ONH neural canal and peri-neural canal (pNC) tissue terminology (Figure 1) to identify and distinguish OCT ONH terminology, (which we argue should be based on OCT-detected anatomic landmarks) from the clinical terms “optic disc” and “peripapillary” because these terms, being based on clinical photographic and clinical biomicroscopic assignment of the clinical disc margin, have no consistent OCT-detectable anatomic foundation in the human eye.17,18 Having no consistent anatomic foundation, the clinical disc margin is inconsistently assigned by clinicians18–20 (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Because the clinical disc margin is commonly used in the definitions of “optic disc tilt” and “torsion” as well as the clinical “gamma” and “delta” zones, its use has also contributed to the lack of anatomically consistent OCT definitions for these terms.3–6,21,22\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) The clinical “optic disc” and “peripapillary” regions are defined relative to the clinical disc margin (see Supplemental Figure 1). (B) We propose that OCT examination of the ONH tissues should be organized relative to the OCT-detected Bruch’s membrane opening (BMO) and neural canal. (C) OCT-radial B-scan from the location depicted by the green line in Panel B. (D) We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axon bundles achieve the retrolaminar orbital optic nerve.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We propose these terms so as to distinguish OCT ONH anatomic terminology from the clinical terms optic disc, papilla, and peri-papillary which have no consistent histologic or OCT-detectable anatomic foundation. (see Supplemental Figure 1)We have previously defined23,24 the ONH anatomically and morphologically (Figures 1 and 2 and Supplemental Figure 1) to include the tissues within the neural canal and those immediately adjacent to it.11,12,23 The ONH tissues thus include not just the retinal ganglion cell (RGC) axons, their associated glia and vasculature and the lamina cribrosa (within the neural canal), but also the scleral flange23–26, the pNC-sclera, choroid and retina, the immediate retrolaminar orbital optic nerve, the dural and pial sheath insertions and the medial portion of the inferior oblique muscle insertion (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For this study the scleral flange opening (SFO) was manually segmented either “geometrically” when identifiable (Panels B2 and C2, see Methods) or, when not geometrically identifiable, estimated visually by projecting the anterior laminar surface through the neural canal wall (Panel A2, see methods). (A3 – C3) Existing BMO and ASCO segmentations in combination with the segmented SFO points were used to define the externally oblique CBT (EOCBT) and Exposed Scleral Flange (ESF) which were parameterized within BMO reference plane as shown in Figure 5.We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axons achieve the orbital optic nerve (Figures 1 and 2 and Supplemental Figure 1).7,10,12,23,27 The pre-scleral neural canal extends from Bruch’s membrane opening, (BMO), through the anterior scleral canal opening, (ASCO) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It consists of the choroidal border tissues (CBT) which are known histologically as the border tissues of Elschnig.27–29 The scleral portion of the neural canal extends from the ASCO through the scleral flange opening (SFO), (when present - see Methods and Figures 1–4), ending at the posterior scleral canal opening (PSCO) which can be identified histologically23,30 but is, at present, only inconsistently visualized by OCT (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "All eyes are shown in right eye orientation.In previous 3D-histomorphometric monkey studies,23,24 we defined the scleral flange to be the portion of the pNC-sclera that was “internal” to the PSCO (Figure 2.) In separate histologic studies in post-mortem human eyes,25,26 Jonas defined the scleral flange to be the portion of the pNC-sclera that was “central “or “internal” to the dural sheath insertion.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Second, scleral flange morphology is influenced by the insertion of the dural sheath into the pNC sclera which adds substantial thickness to the posterior sclera peripheral to the flange.25,26\nIn our recent study,12 we manually segmented BMO, the ASCO and the OCT-determined scleral flange opening (SFO), (when present), in 362 non-highly myopic healthy eyes, so as to report the prevalence, magnitude and Foveal-BMO (FoBMO) location of a new, OCT-defined, ONH region - the “exposed neural canal” (ENC) region (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Pre-scleral and scleral flange neural canal anatomy projected onto the fundus photo of study eye Hi-Myo-GL-29, (also shown in Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figures 1–4 provide illustrations and explanations of the anatomic terms associated with the OCT neural canal and scleral flange.11,12\nFigure 4 illustrates OCT examples of ENC regions and sub-regions within representative Non-Hi-Myo-Healthy and Hi-Myo eyes of this study.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "7,8,68,69\nIn eyes with an ESF region, the SFO,12 was anatomically defined to be the transition between the anterior and internal surfaces of the scleral flange (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was manually segmented “geometrically” (Figure 2, Panels B2 and C2) when the transition from the “anterior” to the “internal” scleral flange surfaces (Figure 2, Panel C2), was acute enough to be visually identified.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes where the transition was not visually discernible (see Discussion), the operator “estimated” the SFO by visually projecting the anterior laminar surface through the neural canal wall (Figure 2, Panel A2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In all instances, and for all segmentations, the operator was able to inspect adjacent B-scans on either side of the B-scan in question to inform their final SFO segmentation choice within a given B-scan.Sectoral ENC, EOCBT and ESF Measurements (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See Figure 3 for the 30° sectoral acronym names shown in Panel E.For each eye, segmented BMO, ASCO and SFO points along with BMO centroid (the centroid of the segmented BMO points) were projected to the BMO reference plane (Figure 5A – 5D) for re-sampled measurement within 30° sectors (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Within each sector, four equally-spaced re-sampling lines were used to measure the radial extent (magnitude) of the EOCBT, ESF and ENC (the sum of the two) regions (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See our previous report12 for a detailed explanation.BMO, ASCO, SFO and Neural Canal Minimum Cross-Sectional Area (NCMCA) Size and Shape Measurements (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Bruch’s membrane opening (BMO), (B) the anterior scleral canal opening (ASCO), (C) the scleral flange opening (SFO) (see Methods) and (D) Neural Canal Minimum Cross-Sectional area (NCMCA) which is an estimate of the smallest dimension of the pre-scleral neural canal through which the retinal ganglion cell axons pass (see Methods and Supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NCMCA (Figure 6 and Supplemental Figure 2)7 estimates the smallest opening that the RGC axons pass through as they move through the pre-scleral neural canal.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The size and ovality index of NCMCA was computed within the projection plane, using the methods described for BMO, the ASCO and the SFO, above.BMO/ASCO Offset Magnitude. (Figure 7 - left).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Subsequently, a best-fit ellipse was fitted to calculate the centroids of both the BMO and ASCO.70,71 The magnitude of BMO/ASCO offset was established by projecting the vector connecting the ASCO and BMO centroids to the BMO reference plane (the BMO/ASCO centroid vector), and transposing it from the projected ASCO centroid to the BMO centroid.BMO/SFO Offset Magnitude (Figure 7 - right).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Global and FoBMO 30° BMO-MRW and pNC-RNFLT data were generated as previously described.12,64 pNC-CT measurements in FoBMO 30⁰ sectors were generated from the 24 radial B-scans, as previously described8,11,12,69 (Supplemental Figure 3). pNC-CT data at the 100, 300, 500 and 700 μm measurement points were represented in microns and as their age-corrected, normative range percentile for each FoBMO sector of each study eye.Subdivision of Study eyes into Hi-ESF and Non-Hi-ESF subgroups.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ENC region sectoral magnitude is greatest and pNC-RNFLT and pNC-CT are thinnest in the inferior-temporal sectors of both the Hi-Myo and Non-Hi-Myo-Healthy eyes (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 4 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the inferior temporal thinning shown in the pNC-CT 300 data included above.The longer sectoral length of the ENC regions and the thinner sectoral thickness of pNC-RNFLT and pNC-CT in the Hi-Myo versus the Non-Hi-Myo-Healthy eyes are also most pronounced within the inferior-temporal sectors.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT at the 300 μm measurement point (pNC-CT 300) data shown in Figure 8.Differences between the Hi-Myo Hi-ESF versus the Non-Hi-Myo-Healthy Hi-ESF eyes (Tables 1–3).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Among the Hi-Myo-GL eyes, while visual field loss was greater in the Hi-ESF compared to the Non-Hi-ESF eyes, this difference did not achieve significance.ENC region sectoral magnitude as well as pNC-RNFLT and pNC-CT are decreased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel), see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 5 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the pNC-CT 300 data included above.Against expectation, while in both groups the inferior temporal sectors demonstrate the highest ENC regional magnitudes and the thinnest pNC-RNFLT and pNC-CT, the sectoral magnitudes of each ENC region and sub-region were decreased rather than increased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (see Discussion).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT-300 data shown in Figure 9.Ocular and Demographic Factors associated with the ENC, EOCBT and ESF regions of the Hi-Myo eyes (Table 7).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "To further clarify these findings, we performed additional univariable and multivariable association studies in “All Study” eyes (Supplemental Table 4, n=484 eyes spanning the full spectrum of axial length and spherical equivalent) and “All Hi-ESF eyes (Supplemental Figure 5, n=160 eyes also spanning the full spectrum of both parameters).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, as would be expected morphologically, (Figure 10), BMO/ASCO offset magnitude consistently predicted the magnitude of the ENC region (except for the “All Study Eye” analysis) and EOCBT region.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "See Table 7 and Supplemental Tables 4 and 5 for the expanded Univariable and Multivariable association data that are summarized herein).Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(Left Panel) The existing exposed neural canal (ENC) region from the 48 year old Hi-Myo-GL-29 example eye from Figure 4 is used to create a “Proposed Longitudinal Change” scenario (Left Middle Panels - top-to-bottom) in which CBT “externalization” and “insertion migration” away from the post-embryonic ASCO creates an ESF region and a geometrically identifiable SFO that is separate from the ASCO.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In this report we have simplified the term to SFO for clarity and now propose that in any cross-sectional OCT images of post-embryonic eyes, (i.e., at any post-embryonic point in life at which the eye is imaged), at radial ONH locations where an SFO point can be identified separate from an ASCO point, the SFO point is the “original” (i.e., “post-embryonic development” or “pre-myopic neural canal remodeling”) entrance to the scleral flange portion of the neural canal.12 (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Likewise, the SFO as an opening, represents the “entrance” to the scleral flange portion of the neural canal at the end of neural canal embryonic development, (though its size, shape and planarity may also have been altered by postembryonic remodeling).12 In this same construct, the ASCO, as detected in the same images, represents the “entrance” to the scleral flange portion of the neural canal after whatever post-embryonic remodeling of the CBT (Figure 10)13 has occurred.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 10, (modified from our previous report),12 uses the Hi-Myo-GL-29 eye from Figure 4 to create a “Proposed Longitudinal Change” scenario in which CBT “externalization” and “insertion migration” away from the “embryonic” entrance to the scleral flange portion of the neural canal creates an ESF region as well as an ASCO point that is separate from a geometrically identifiable SFO point.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 10 also includes a second, “Alternative Longitudinal Change” scenario, in which the CBT become externalized and then elongate progressively without losing their insertion into the post-embryonic ASCO point creating an ENC region that consists entirely of EOCBT.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 11 illustrates how increased peri-neural canal scleral bowing (pNC-SB) and increased neural canal scleral flange bowing (neither of which having been reported in this study) in the Hi-Myo-GL eyes may have increased the “axial” orientation of the scleral flange and in so doing reduced the “transverse extent” of the exposed neural canal (ENC) regions in the Hi-Myo-GL eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "We have previously reported that pNC-SB is greater in the Halifax subset of the Hi-Myo-GL eyes (see methods) compared to the Halifax Hi-Myo-Healthy eyes of this study.11 In a manuscript in preparation, we will measure both neural canal scleral flange bowing (Supplemental Figure 6)11 and “running length” (rather than) “projected length” measures of each ENC region in an expanded group of Hi-Myo-GL versus Hi-Myo-Healthy eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Other Acknowledgments\nAnuwat Jiravarnsirikul and Hongli Yang contributed equally to this work.Abbreviations/Acronyms:\n\nASCO\nanterior sclera canal opening\nBM\nBruch’s Membrane\nBMO\nBruch’s membrane opening\nCBT\nChoroidal Border Tissues – previously referred to by their histologic name (“Border tissues of Elschnig”)\nCCT\ncentral corneal thickness\nCDM\nclinical disc margin\nCSF\nCerebrospinal Fluid\nDIGS\nDiagnostic Innovations in Glaucoma Study\nENC\nexposed Neural Canal\nEOCBT\nExternally Oblique CBT\nESF\nExposed Scleral Flange\nFDA\nFood and Drug Administration\nFoBMO\nFoveal-BMO\nGHT\nGlaucoma Hemifield Test\nHi-ESF\nStudy Eyes in which the ESF region is ≥ 100 μms in at least one sector\nHi-Myo\nHighly myopic eyes\nHi-Myo-Healthy\nHighly myopic healthy eyes\nHi-Myo-GL\nHighly myopic eyes with glaucoma\nIOCBT\nInternally Oblique Choroidal Border Tissues\nIOP\nIntraocular pressure\nMD\nMean Deviation\nMRW\nMinimum Rim Width\nNC\nNeural Canal\nNCMCA\nNeural Canal Minimum Cross-Sectional Area\nNCSFB\nneural canal scleral flange bowing\nNon-Hi-ESF\nStudy eyes in which the ESF region is < 100 μms in all sectors\nNon-Hi-Myo-Healthy\nNon-highly myopic healthy eyes\nPSCO\nPosterior Scleral Canal Opening (Not segmented in this study)\nOCT\noptical coherence tomography\nONH\noptic nerve head\npNC\nperineural canal\npNC-CT\nperineural canal choroidal thickness\npNC-SB\nperineural canal scleral bowing\nRNFL\nretinal nerve fiber layer\nRNFLT\nRNFL thickness\nRPE\nRetinal Pigment Epithelium\nSector\nONH FoBMO 30° (clock-hour) sectors (see Figure 2, Panel (A))\nSFO\nScleral Flange Opening\nSD\nstandard deviation\nSE\nspherical equivalent\nUCSD\nUniversity of California, San Diego\nFootnotes\nPublisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In their absence, the field has only recently begun to build an OCT-based conceptual framework for parameterizing longitudinal “myopic” ONH remodeling.13–16\nIn recent publications,11,12 we have introduced OCT-defined, ONH neural canal and peri-neural canal (pNC) tissue terminology (Figure 1) to identify and distinguish OCT ONH terminology, (which we argue should be based on OCT-detected anatomic landmarks) from the clinical terms “optic disc” and “peripapillary” because these terms, being based on clinical photographic and clinical biomicroscopic assignment of the clinical disc margin, have no consistent OCT-detectable anatomic foundation in the human eye.17,18 Having no consistent anatomic foundation, the clinical disc margin is inconsistently assigned by clinicians18–20 (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Because the clinical disc margin is commonly used in the definitions of “optic disc tilt” and “torsion” as well as the clinical “gamma” and “delta” zones, its use has also contributed to the lack of anatomically consistent OCT definitions for these terms.3–6,21,22\nFigure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) The clinical “optic disc” and “peripapillary” regions are defined relative to the clinical disc margin (see Supplemental Figure 1). (B) We propose that OCT examination of the ONH tissues should be organized relative to the OCT-detected Bruch’s membrane opening (BMO) and neural canal. (C) OCT-radial B-scan from the location depicted by the green line in Panel B. (D) We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axon bundles achieve the retrolaminar orbital optic nerve.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We propose these terms so as to distinguish OCT ONH anatomic terminology from the clinical terms optic disc, papilla, and peri-papillary which have no consistent histologic or OCT-detectable anatomic foundation. (see Supplemental Figure 1)We have previously defined23,24 the ONH anatomically and morphologically (Figures 1 and 2 and Supplemental Figure 1) to include the tissues within the neural canal and those immediately adjacent to it.11,12,23 The ONH tissues thus include not just the retinal ganglion cell (RGC) axons, their associated glia and vasculature and the lamina cribrosa (within the neural canal), but also the scleral flange23–26, the pNC-sclera, choroid and retina, the immediate retrolaminar orbital optic nerve, the dural and pial sheath insertions and the medial portion of the inferior oblique muscle insertion (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For this study the scleral flange opening (SFO) was manually segmented either “geometrically” when identifiable (Panels B2 and C2, see Methods) or, when not geometrically identifiable, estimated visually by projecting the anterior laminar surface through the neural canal wall (Panel A2, see methods). (A3 – C3) Existing BMO and ASCO segmentations in combination with the segmented SFO points were used to define the externally oblique CBT (EOCBT) and Exposed Scleral Flange (ESF) which were parameterized within BMO reference plane as shown in Figure 5.We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axons achieve the orbital optic nerve (Figures 1 and 2 and Supplemental Figure 1).7,10,12,23,27 The pre-scleral neural canal extends from Bruch’s membrane opening, (BMO), through the anterior scleral canal opening, (ASCO) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It consists of the choroidal border tissues (CBT) which are known histologically as the border tissues of Elschnig.27–29 The scleral portion of the neural canal extends from the ASCO through the scleral flange opening (SFO), (when present - see Methods and Figures 1–4), ending at the posterior scleral canal opening (PSCO) which can be identified histologically23,30 but is, at present, only inconsistently visualized by OCT (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "All eyes are shown in right eye orientation.In previous 3D-histomorphometric monkey studies,23,24 we defined the scleral flange to be the portion of the pNC-sclera that was “internal” to the PSCO (Figure 2.) In separate histologic studies in post-mortem human eyes,25,26 Jonas defined the scleral flange to be the portion of the pNC-sclera that was “central “or “internal” to the dural sheath insertion.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Second, scleral flange morphology is influenced by the insertion of the dural sheath into the pNC sclera which adds substantial thickness to the posterior sclera peripheral to the flange.25,26\nIn our recent study,12 we manually segmented BMO, the ASCO and the OCT-determined scleral flange opening (SFO), (when present), in 362 non-highly myopic healthy eyes, so as to report the prevalence, magnitude and Foveal-BMO (FoBMO) location of a new, OCT-defined, ONH region - the “exposed neural canal” (ENC) region (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Pre-scleral and scleral flange neural canal anatomy projected onto the fundus photo of study eye Hi-Myo-GL-29, (also shown in Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In recent publications,11,12 we have introduced OCT-defined, ONH neural canal and peri-neural canal (pNC) tissue terminology (Figure 1) to identify and distinguish OCT ONH terminology, (which we argue should be based on OCT-detected anatomic landmarks) from the clinical terms “optic disc” and “peripapillary” because these terms, being based on clinical photographic and clinical biomicroscopic assignment of the clinical disc margin, have no consistent OCT-detectable anatomic foundation in the human eye.17,18 Having no consistent anatomic foundation, the clinical disc margin is inconsistently assigned by clinicians18–20 (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "(A) The clinical “optic disc” and “peripapillary” regions are defined relative to the clinical disc margin (see Supplemental Figure 1). (B) We propose that OCT examination of the ONH tissues should be organized relative to the OCT-detected Bruch’s membrane opening (BMO) and neural canal. (C) OCT-radial B-scan from the location depicted by the green line in Panel B. (D) We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axon bundles achieve the retrolaminar orbital optic nerve.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We propose these terms so as to distinguish OCT ONH anatomic terminology from the clinical terms optic disc, papilla, and peri-papillary which have no consistent histologic or OCT-detectable anatomic foundation. (see Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "We have previously defined23,24 the ONH anatomically and morphologically (Figures 1 and 2 and Supplemental Figure 1) to include the tissues within the neural canal and those immediately adjacent to it.11,12,23 The ONH tissues thus include not just the retinal ganglion cell (RGC) axons, their associated glia and vasculature and the lamina cribrosa (within the neural canal), but also the scleral flange23–26, the pNC-sclera, choroid and retina, the immediate retrolaminar orbital optic nerve, the dural and pial sheath insertions and the medial portion of the inferior oblique muscle insertion (Supplemental Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "For this study the scleral flange opening (SFO) was manually segmented either “geometrically” when identifiable (Panels B2 and C2, see Methods) or, when not geometrically identifiable, estimated visually by projecting the anterior laminar surface through the neural canal wall (Panel A2, see methods). (A3 – C3) Existing BMO and ASCO segmentations in combination with the segmented SFO points were used to define the externally oblique CBT (EOCBT) and Exposed Scleral Flange (ESF) which were parameterized within BMO reference plane as shown in Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "We define the neural canal to be the connective tissue pathway through the choroid and sclera through which the RGC axons achieve the orbital optic nerve (Figures 1 and 2 and Supplemental Figure 1).7,10,12,23,27 The pre-scleral neural canal extends from Bruch’s membrane opening, (BMO), through the anterior scleral canal opening, (ASCO) (Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "It consists of the choroidal border tissues (CBT) which are known histologically as the border tissues of Elschnig.27–29 The scleral portion of the neural canal extends from the ASCO through the scleral flange opening (SFO), (when present - see Methods and Figures 1–4), ending at the posterior scleral canal opening (PSCO) which can be identified histologically23,30 but is, at present, only inconsistently visualized by OCT (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In previous 3D-histomorphometric monkey studies,23,24 we defined the scleral flange to be the portion of the pNC-sclera that was “internal” to the PSCO (Figure 2.) In separate histologic studies in post-mortem human eyes,25,26 Jonas defined the scleral flange to be the portion of the pNC-sclera that was “central “or “internal” to the dural sheath insertion.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In our recent study,12 we manually segmented BMO, the ASCO and the OCT-determined scleral flange opening (SFO), (when present), in 362 non-highly myopic healthy eyes, so as to report the prevalence, magnitude and Foveal-BMO (FoBMO) location of a new, OCT-defined, ONH region - the “exposed neural canal” (ENC) region (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "(A) Pre-scleral and scleral flange neural canal anatomy projected onto the fundus photo of study eye Hi-Myo-GL-29, (also shown in Figure 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figures 1–4 provide illustrations and explanations of the anatomic terms associated with the OCT neural canal and scleral flange.11,12\nFigure 4 illustrates OCT examples of ENC regions and sub-regions within representative Non-Hi-Myo-Healthy and Hi-Myo eyes of this study.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "7,8,68,69\nIn eyes with an ESF region, the SFO,12 was anatomically defined to be the transition between the anterior and internal surfaces of the scleral flange (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was manually segmented “geometrically” (Figure 2, Panels B2 and C2) when the transition from the “anterior” to the “internal” scleral flange surfaces (Figure 2, Panel C2), was acute enough to be visually identified.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes where the transition was not visually discernible (see Discussion), the operator “estimated” the SFO by visually projecting the anterior laminar surface through the neural canal wall (Figure 2, Panel A2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In all instances, and for all segmentations, the operator was able to inspect adjacent B-scans on either side of the B-scan in question to inform their final SFO segmentation choice within a given B-scan.Sectoral ENC, EOCBT and ESF Measurements (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See Figure 3 for the 30° sectoral acronym names shown in Panel E.For each eye, segmented BMO, ASCO and SFO points along with BMO centroid (the centroid of the segmented BMO points) were projected to the BMO reference plane (Figure 5A – 5D) for re-sampled measurement within 30° sectors (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Within each sector, four equally-spaced re-sampling lines were used to measure the radial extent (magnitude) of the EOCBT, ESF and ENC (the sum of the two) regions (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See our previous report12 for a detailed explanation.BMO, ASCO, SFO and Neural Canal Minimum Cross-Sectional Area (NCMCA) Size and Shape Measurements (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Bruch’s membrane opening (BMO), (B) the anterior scleral canal opening (ASCO), (C) the scleral flange opening (SFO) (see Methods) and (D) Neural Canal Minimum Cross-Sectional area (NCMCA) which is an estimate of the smallest dimension of the pre-scleral neural canal through which the retinal ganglion cell axons pass (see Methods and Supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NCMCA (Figure 6 and Supplemental Figure 2)7 estimates the smallest opening that the RGC axons pass through as they move through the pre-scleral neural canal.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The size and ovality index of NCMCA was computed within the projection plane, using the methods described for BMO, the ASCO and the SFO, above.BMO/ASCO Offset Magnitude. (Figure 7 - left).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Subsequently, a best-fit ellipse was fitted to calculate the centroids of both the BMO and ASCO.70,71 The magnitude of BMO/ASCO offset was established by projecting the vector connecting the ASCO and BMO centroids to the BMO reference plane (the BMO/ASCO centroid vector), and transposing it from the projected ASCO centroid to the BMO centroid.BMO/SFO Offset Magnitude (Figure 7 - right).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Global and FoBMO 30° BMO-MRW and pNC-RNFLT data were generated as previously described.12,64 pNC-CT measurements in FoBMO 30⁰ sectors were generated from the 24 radial B-scans, as previously described8,11,12,69 (Supplemental Figure 3). pNC-CT data at the 100, 300, 500 and 700 μm measurement points were represented in microns and as their age-corrected, normative range percentile for each FoBMO sector of each study eye.Subdivision of Study eyes into Hi-ESF and Non-Hi-ESF subgroups.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figures 1–4 provide illustrations and explanations of the anatomic terms associated with the OCT neural canal and scleral flange.11,12\nFigure 4 illustrates OCT examples of ENC regions and sub-regions within representative Non-Hi-Myo-Healthy and Hi-Myo eyes of this study.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figures 1–4 provide illustrations and explanations of the anatomic terms associated with the OCT neural canal and scleral flange.11,12\nFigure 4 illustrates OCT examples of ENC regions and sub-regions within representative Non-Hi-Myo-Healthy and Hi-Myo eyes of this study.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "7,8,68,69\nIn eyes with an ESF region, the SFO,12 was anatomically defined to be the transition between the anterior and internal surfaces of the scleral flange (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was manually segmented “geometrically” (Figure 2, Panels B2 and C2) when the transition from the “anterior” to the “internal” scleral flange surfaces (Figure 2, Panel C2), was acute enough to be visually identified.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes where the transition was not visually discernible (see Discussion), the operator “estimated” the SFO by visually projecting the anterior laminar surface through the neural canal wall (Figure 2, Panel A2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes with an ESF region, the SFO,12 was anatomically defined to be the transition between the anterior and internal surfaces of the scleral flange (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "It was manually segmented “geometrically” (Figure 2, Panels B2 and C2) when the transition from the “anterior” to the “internal” scleral flange surfaces (Figure 2, Panel C2), was acute enough to be visually identified.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In eyes where the transition was not visually discernible (see Discussion), the operator “estimated” the SFO by visually projecting the anterior laminar surface through the neural canal wall (Figure 2, Panel A2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Sectoral ENC, EOCBT and ESF Measurements (Figure 5).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See Figure 3 for the 30° sectoral acronym names shown in Panel E.For each eye, segmented BMO, ASCO and SFO points along with BMO centroid (the centroid of the segmented BMO points) were projected to the BMO reference plane (Figure 5A – 5D) for re-sampled measurement within 30° sectors (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Within each sector, four equally-spaced re-sampling lines were used to measure the radial extent (magnitude) of the EOCBT, ESF and ENC (the sum of the two) regions (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "See Figure 3 for the 30° sectoral acronym names shown in Panel E.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "For each eye, segmented BMO, ASCO and SFO points along with BMO centroid (the centroid of the segmented BMO points) were projected to the BMO reference plane (Figure 5A – 5D) for re-sampled measurement within 30° sectors (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Within each sector, four equally-spaced re-sampling lines were used to measure the radial extent (magnitude) of the EOCBT, ESF and ENC (the sum of the two) regions (Figure 5E).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel E",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "BMO, ASCO, SFO and Neural Canal Minimum Cross-Sectional Area (NCMCA) Size and Shape Measurements (Figure 6).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(A) Bruch’s membrane opening (BMO), (B) the anterior scleral canal opening (ASCO), (C) the scleral flange opening (SFO) (see Methods) and (D) Neural Canal Minimum Cross-Sectional area (NCMCA) which is an estimate of the smallest dimension of the pre-scleral neural canal through which the retinal ganglion cell axons pass (see Methods and Supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NCMCA (Figure 6 and Supplemental Figure 2)7 estimates the smallest opening that the RGC axons pass through as they move through the pre-scleral neural canal.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "(A) Bruch’s membrane opening (BMO), (B) the anterior scleral canal opening (ASCO), (C) the scleral flange opening (SFO) (see Methods) and (D) Neural Canal Minimum Cross-Sectional area (NCMCA) which is an estimate of the smallest dimension of the pre-scleral neural canal through which the retinal ganglion cell axons pass (see Methods and Supplemental Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "NCMCA (Figure 6 and Supplemental Figure 2)7 estimates the smallest opening that the RGC axons pass through as they move through the pre-scleral neural canal.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "BMO/ASCO Offset Magnitude. (Figure 7 - left).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "BMO/SFO Offset Magnitude (Figure 7 - right).",
    "figure_references": [
      {
        "figure_number": "Figure 7",
        "panel": "",
        "figure_key": "figure_7"
      }
    ]
  },
  {
    "sentence": "Global and FoBMO 30° BMO-MRW and pNC-RNFLT data were generated as previously described.12,64 pNC-CT measurements in FoBMO 30⁰ sectors were generated from the 24 radial B-scans, as previously described8,11,12,69 (Supplemental Figure 3). pNC-CT data at the 100, 300, 500 and 700 μm measurement points were represented in microns and as their age-corrected, normative range percentile for each FoBMO sector of each study eye.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Global and FoBMO 30° BMO-MRW and pNC-RNFLT data were generated as previously described.12,64 pNC-CT measurements in FoBMO 30⁰ sectors were generated from the 24 radial B-scans, as previously described8,11,12,69 (Supplemental Figure 3). pNC-CT data at the 100, 300, 500 and 700 μm measurement points were represented in microns and as their age-corrected, normative range percentile for each FoBMO sector of each study eye.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "ENC region sectoral magnitude is greatest and pNC-RNFLT and pNC-CT are thinnest in the inferior-temporal sectors of both the Hi-Myo and Non-Hi-Myo-Healthy eyes (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 4 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the inferior temporal thinning shown in the pNC-CT 300 data included above.The longer sectoral length of the ENC regions and the thinner sectoral thickness of pNC-RNFLT and pNC-CT in the Hi-Myo versus the Non-Hi-Myo-Healthy eyes are also most pronounced within the inferior-temporal sectors.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT at the 300 μm measurement point (pNC-CT 300) data shown in Figure 8.Differences between the Hi-Myo Hi-ESF versus the Non-Hi-Myo-Healthy Hi-ESF eyes (Tables 1–3).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "Among the Hi-Myo-GL eyes, while visual field loss was greater in the Hi-ESF compared to the Non-Hi-ESF eyes, this difference did not achieve significance.ENC region sectoral magnitude as well as pNC-RNFLT and pNC-CT are decreased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel), see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 5 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the pNC-CT 300 data included above.Against expectation, while in both groups the inferior temporal sectors demonstrate the highest ENC regional magnitudes and the thinnest pNC-RNFLT and pNC-CT, the sectoral magnitudes of each ENC region and sub-region were decreased rather than increased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (see Discussion).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT-300 data shown in Figure 9.Ocular and Demographic Factors associated with the ENC, EOCBT and ESF regions of the Hi-Myo eyes (Table 7).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "ENC region sectoral magnitude is greatest and pNC-RNFLT and pNC-CT are thinnest in the inferior-temporal sectors of both the Hi-Myo and Non-Hi-Myo-Healthy eyes (Figure 8).",
    "figure_references": [
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 4 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the inferior temporal thinning shown in the pNC-CT 300 data included above.The longer sectoral length of the ENC regions and the thinner sectoral thickness of pNC-RNFLT and pNC-CT in the Hi-Myo versus the Non-Hi-Myo-Healthy eyes are also most pronounced within the inferior-temporal sectors.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT at the 300 μm measurement point (pNC-CT 300) data shown in Figure 8.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 4 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the inferior temporal thinning shown in the pNC-CT 300 data included above.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT at the 300 μm measurement point (pNC-CT 300) data shown in Figure 8.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      },
      {
        "figure_number": "Figure 8",
        "panel": "",
        "figure_key": "figure_8"
      }
    ]
  },
  {
    "sentence": "ENC region sectoral magnitude as well as pNC-RNFLT and pNC-CT are decreased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (Figure 9).",
    "figure_references": [
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel), see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 5 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the pNC-CT 300 data included above.Against expectation, while in both groups the inferior temporal sectors demonstrate the highest ENC regional magnitudes and the thinnest pNC-RNFLT and pNC-CT, the sectoral magnitudes of each ENC region and sub-region were decreased rather than increased in the Hi-Myo-GL compared to the Hi-Myo-Healthy eyes (see Discussion).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT-300 data shown in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel), see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "See Supplemental Figure 5 for pNC-CT measurement data at the 100, 700 and 1100 um measurement points which confirm the pNC-CT 300 data included above.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5 reports FoBMO sectoral mean pNC-CT data at all four pNC-CT measurement points that is consistent with the pNC-CT-300 data shown in Figure 9.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 9",
        "panel": "",
        "figure_key": "figure_9"
      }
    ]
  },
  {
    "sentence": "To further clarify these findings, we performed additional univariable and multivariable association studies in “All Study” eyes (Supplemental Table 4, n=484 eyes spanning the full spectrum of axial length and spherical equivalent) and “All Hi-ESF eyes (Supplemental Figure 5, n=160 eyes also spanning the full spectrum of both parameters).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, as would be expected morphologically, (Figure 10), BMO/ASCO offset magnitude consistently predicted the magnitude of the ENC region (except for the “All Study Eye” analysis) and EOCBT region.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "See Table 7 and Supplemental Tables 4 and 5 for the expanded Univariable and Multivariable association data that are summarized herein).Figure 10.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Open in a new tab\n(Left Panel) The existing exposed neural canal (ENC) region from the 48 year old Hi-Myo-GL-29 example eye from Figure 4 is used to create a “Proposed Longitudinal Change” scenario (Left Middle Panels - top-to-bottom) in which CBT “externalization” and “insertion migration” away from the post-embryonic ASCO creates an ESF region and a geometrically identifiable SFO that is separate from the ASCO.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In this report we have simplified the term to SFO for clarity and now propose that in any cross-sectional OCT images of post-embryonic eyes, (i.e., at any post-embryonic point in life at which the eye is imaged), at radial ONH locations where an SFO point can be identified separate from an ASCO point, the SFO point is the “original” (i.e., “post-embryonic development” or “pre-myopic neural canal remodeling”) entrance to the scleral flange portion of the neural canal.12 (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Likewise, the SFO as an opening, represents the “entrance” to the scleral flange portion of the neural canal at the end of neural canal embryonic development, (though its size, shape and planarity may also have been altered by postembryonic remodeling).12 In this same construct, the ASCO, as detected in the same images, represents the “entrance” to the scleral flange portion of the neural canal after whatever post-embryonic remodeling of the CBT (Figure 10)13 has occurred.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 10, (modified from our previous report),12 uses the Hi-Myo-GL-29 eye from Figure 4 to create a “Proposed Longitudinal Change” scenario in which CBT “externalization” and “insertion migration” away from the “embryonic” entrance to the scleral flange portion of the neural canal creates an ESF region as well as an ASCO point that is separate from a geometrically identifiable SFO point.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 10 also includes a second, “Alternative Longitudinal Change” scenario, in which the CBT become externalized and then elongate progressively without losing their insertion into the post-embryonic ASCO point creating an ENC region that consists entirely of EOCBT.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 11 illustrates how increased peri-neural canal scleral bowing (pNC-SB) and increased neural canal scleral flange bowing (neither of which having been reported in this study) in the Hi-Myo-GL eyes may have increased the “axial” orientation of the scleral flange and in so doing reduced the “transverse extent” of the exposed neural canal (ENC) regions in the Hi-Myo-GL eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "We have previously reported that pNC-SB is greater in the Halifax subset of the Hi-Myo-GL eyes (see methods) compared to the Halifax Hi-Myo-Healthy eyes of this study.11 In a manuscript in preparation, we will measure both neural canal scleral flange bowing (Supplemental Figure 6)11 and “running length” (rather than) “projected length” measures of each ENC region in an expanded group of Hi-Myo-GL versus Hi-Myo-Healthy eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "To further clarify these findings, we performed additional univariable and multivariable association studies in “All Study” eyes (Supplemental Table 4, n=484 eyes spanning the full spectrum of axial length and spherical equivalent) and “All Hi-ESF eyes (Supplemental Figure 5, n=160 eyes also spanning the full spectrum of both parameters).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "However, as would be expected morphologically, (Figure 10), BMO/ASCO offset magnitude consistently predicted the magnitude of the ENC region (except for the “All Study Eye” analysis) and EOCBT region.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "(Left Panel) The existing exposed neural canal (ENC) region from the 48 year old Hi-Myo-GL-29 example eye from Figure 4 is used to create a “Proposed Longitudinal Change” scenario (Left Middle Panels - top-to-bottom) in which CBT “externalization” and “insertion migration” away from the post-embryonic ASCO creates an ESF region and a geometrically identifiable SFO that is separate from the ASCO.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In this report we have simplified the term to SFO for clarity and now propose that in any cross-sectional OCT images of post-embryonic eyes, (i.e., at any post-embryonic point in life at which the eye is imaged), at radial ONH locations where an SFO point can be identified separate from an ASCO point, the SFO point is the “original” (i.e., “post-embryonic development” or “pre-myopic neural canal remodeling”) entrance to the scleral flange portion of the neural canal.12 (Figure 11).",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      },
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "Likewise, the SFO as an opening, represents the “entrance” to the scleral flange portion of the neural canal at the end of neural canal embryonic development, (though its size, shape and planarity may also have been altered by postembryonic remodeling).12 In this same construct, the ASCO, as detected in the same images, represents the “entrance” to the scleral flange portion of the neural canal after whatever post-embryonic remodeling of the CBT (Figure 10)13 has occurred.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 10, (modified from our previous report),12 uses the Hi-Myo-GL-29 eye from Figure 4 to create a “Proposed Longitudinal Change” scenario in which CBT “externalization” and “insertion migration” away from the “embryonic” entrance to the scleral flange portion of the neural canal creates an ESF region as well as an ASCO point that is separate from a geometrically identifiable SFO point.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      },
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 10 also includes a second, “Alternative Longitudinal Change” scenario, in which the CBT become externalized and then elongate progressively without losing their insertion into the post-embryonic ASCO point creating an ENC region that consists entirely of EOCBT.",
    "figure_references": [
      {
        "figure_number": "Figure 10",
        "panel": "",
        "figure_key": "figure_10"
      }
    ]
  },
  {
    "sentence": "Figure 11 illustrates how increased peri-neural canal scleral bowing (pNC-SB) and increased neural canal scleral flange bowing (neither of which having been reported in this study) in the Hi-Myo-GL eyes may have increased the “axial” orientation of the scleral flange and in so doing reduced the “transverse extent” of the exposed neural canal (ENC) regions in the Hi-Myo-GL eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 11",
        "panel": "",
        "figure_key": "figure_11"
      }
    ]
  },
  {
    "sentence": "We have previously reported that pNC-SB is greater in the Halifax subset of the Hi-Myo-GL eyes (see methods) compared to the Halifax Hi-Myo-Healthy eyes of this study.11 In a manuscript in preparation, we will measure both neural canal scleral flange bowing (Supplemental Figure 6)11 and “running length” (rather than) “projected length” measures of each ENC region in an expanded group of Hi-Myo-GL versus Hi-Myo-Healthy eyes.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Abbreviations/Acronyms:\n\nASCO\nanterior sclera canal opening\nBM\nBruch’s Membrane\nBMO\nBruch’s membrane opening\nCBT\nChoroidal Border Tissues – previously referred to by their histologic name (“Border tissues of Elschnig”)\nCCT\ncentral corneal thickness\nCDM\nclinical disc margin\nCSF\nCerebrospinal Fluid\nDIGS\nDiagnostic Innovations in Glaucoma Study\nENC\nexposed Neural Canal\nEOCBT\nExternally Oblique CBT\nESF\nExposed Scleral Flange\nFDA\nFood and Drug Administration\nFoBMO\nFoveal-BMO\nGHT\nGlaucoma Hemifield Test\nHi-ESF\nStudy Eyes in which the ESF region is ≥ 100 μms in at least one sector\nHi-Myo\nHighly myopic eyes\nHi-Myo-Healthy\nHighly myopic healthy eyes\nHi-Myo-GL\nHighly myopic eyes with glaucoma\nIOCBT\nInternally Oblique Choroidal Border Tissues\nIOP\nIntraocular pressure\nMD\nMean Deviation\nMRW\nMinimum Rim Width\nNC\nNeural Canal\nNCMCA\nNeural Canal Minimum Cross-Sectional Area\nNCSFB\nneural canal scleral flange bowing\nNon-Hi-ESF\nStudy eyes in which the ESF region is < 100 μms in all sectors\nNon-Hi-Myo-Healthy\nNon-highly myopic healthy eyes\nPSCO\nPosterior Scleral Canal Opening (Not segmented in this study)\nOCT\noptical coherence tomography\nONH\noptic nerve head\npNC\nperineural canal\npNC-CT\nperineural canal choroidal thickness\npNC-SB\nperineural canal scleral bowing\nRNFL\nretinal nerve fiber layer\nRNFLT\nRNFL thickness\nRPE\nRetinal Pigment Epithelium\nSector\nONH FoBMO 30° (clock-hour) sectors (see Figure 2, Panel (A))\nSFO\nScleral Flange Opening\nSD\nstandard deviation\nSE\nspherical equivalent\nUCSD\nUniversity of California, San Diego.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "ONH FoBMO 30° (clock-hour) sectors (see Figure 2, Panel (A)).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 5.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "All 30° sectoral data are in right eye orientation (upper left panel, see Figure 3 legend for the sectoral acronym definitions).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Supplemental Figure 6.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "",
        "figure_key": "figure_6"
      }
    ]
  }
]